Full Report

Industry — Vertical Market Software (VMS)

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

1. Industry in One Page

Vertical Market Software (VMS) is software built for one industry's workflow — the booking system a Dutch driving school runs on, the case file a German notary opens, the patient record a Belgian dentist edits. Each product is small (often $1–60m of revenue, a few thousand customers), embedded in the customer's daily operations, and almost never replaced. That combination — narrow market, mission-critical use, high switching cost — produces resilient maintenance revenue and free cash flow margins north of 25% at scale, but it also caps single-product growth in the low single digits. The industry's economic engine is therefore not building bigger products; it is buying more small products with disciplined capital and running them flat for decades.

The reader's mental model should start here: the public VMS leaders are not really software companies in the SaaS sense. They are capital-allocation platforms that happen to own software. Topicus, its parent Constellation, sibling Lumine, and US analog Roper all earn their multiples on the same mechanic — collect cash from sticky niche software, redeploy it into more sticky niche software at a high internal hurdle rate, repeat. The one thing newcomers get wrong: assuming organic growth matters most. In this industry, incremental-IRR-on-deployed-cash matters most, and a 4% organic year with $470m of acquisitions can compound faster than a 20% organic year with no acquisitions.

Takeaway: VMS is a four-layer stack. The aggregators sit between thousands of small product vendors and a small group of public-market investors — and they capture the arbitrage between the two.

2. How This Industry Makes Money

A single VMS product earns 70%+ of revenue from maintenance-and-other-recurring fees — predictable annual contracts that include the right to product updates. The rest is professional services (implementation, customisation, integration — often 20–25% of revenue and stickier than it looks because every customisation deepens lock-in), license fees (one-time or multi-year), and a small hardware resale tail in industries like POS, healthcare, and automotive. Topicus's FY2025 mix is the cleanest illustration of the model on European public markets.

The margin stack tells you where the value sits. Gross margin is mid-30s on an as-reported basis but ~70%+ on a pure-software basis — the reported number is depressed by professional-services labour and hardware pass-through that are accounted for in cost of revenue. EBITDA margins land in the high 20s. The real profitability metric in this industry is free cash flow margin, because depreciation and amortisation of acquired intangibles is heavy ($240m in FY2025 for Topicus, or 13% of revenue) and largely non-cash. Topicus prints 26% FCF margin on $1,824m of revenue; that is the industry standard for a well-run VMS portfolio at scale.

Where bargaining power sits: strongly with the VMS vendor, not the customer. Annual price escalators of 3–8% are typical because the cost of switching exceeds the savings. The customer base is fragmented — no single end-customer is large enough to demand discounts. Suppliers are essentially staff (60–65% of operating expense is people) and a small slice of third-party software and hardware. Capital intensity is unusually low: Topicus's capex is 0.7% of revenue. The capital that does get spent goes into M&A, where it is recorded as an investing outflow rather than a P&L cost — which is why GAAP/IFRS earnings systematically understate the economic value of these businesses.

3. Demand, Supply, and the Cycle

VMS demand is non-cyclical in the customer's purchase decision: a dentist does not stop running her practice management software in a recession, a municipality does not turn off its tax-collection system when GDP falls. What changes is the price of inputs to the aggregator: when end markets and IT budgets weaken, end-customer churn ticks up modestly and seller expectations for acquisition multiples reset down — which is when serial acquirers deploy the most capital. The 2022–2023 software derating produced exactly this pattern; private VMS owners in Europe became more willing to sell, and aggregator deployment accelerated.

Where the cycle hits first: not in revenue or backlog, but in professional-services bookings (customers defer customisation projects) and in deal flow and multiples (private sellers reset expectations). The textbook downside playbook here is that maintenance revenue holds steady, services revenue softens, and acquisition spend accelerates because seller expectations fall. The 2022–2024 European software downturn followed this exact script: Topicus's maintenance organic growth held in the +6–7% band throughout, services organic growth drifted from +3% (2022) to -2% (FY2025), and acquisition deployment in 2025 was larger than the prior three years combined as private valuations came in.

4. Competitive Structure

VMS aggregation is structurally a fragmented industry of fragmented industries. There are an estimated 20,000+ niche software vendors in Europe alone, mostly private, mostly family-owned or founder-run, mostly under $25m of revenue. No buyer has more than a sliver: even Constellation, the global leader, has only ~1,100 completed acquisitions and ~$9–12bn of acquired revenue — a tiny share of the long tail. The competitive game is therefore not pricing or share at the product level; the question is who builds the best deal-sourcing and underwriting engine at the aggregator level.

The competitive structure has three distinct tiers and one wildcard. Tier 1 is the public Canadian VMS family — Constellation, Topicus, Lumine — all running the same Mark Leonard playbook with shared back-office, shared M&A databases, and shared culture. They are structurally non-competitive: each focuses on different geographies/verticals and they refer deals to each other. Tier 2 is the US-listed aggregators (Roper, Tyler) which operate at larger deal sizes ($100m+ per transaction) and rarely chase the sub-$25m European deals Topicus prefers — so they overlap in benchmark, not in pipeline. Tier 3 is private European competitors (Visma, Chapter, regional PE-backed roll-ups) that do compete with Topicus deal-by-deal in the Benelux/DACH/Nordic deal funnel. The wildcard is generalist private equity and family offices, which have entered the VMS deal funnel since 2020 attracted by recurring-revenue economics — pushing multiples paid up by 1–2 turns of revenue versus the pre-2020 norm.

Read: TOI sits in the middle of the EV/Sales pack but commands an EBITDA multiple in line with much larger ROP — investors are paying for the deployment runway, not current scale.

5. Regulation, Technology, and Rules of the Game

VMS is normally a regulation-light industry — there is no FDA, no spectrum auction, no carbon cap. But three external rule sets do materially shape the economics, and one technology shift dominates every recent investor conversation.

The AI question is the only technology debate that matters for the VMS sector right now. The bear case is that large language models commoditise the "build" cost of vertical workflow software, letting customers self-assemble replacements; the bull case is that VMS products are not really about code — they are about deeply encoded domain logic, regulatory compliance, integrations with national tax/health/court systems, and accumulated customer customisations that no LLM can simply regenerate. Topicus's own FY2025 risk factor language acknowledges AI as both a competitive risk and a productivity opportunity for its R&D base. The empirical signal so far: maintenance churn has not moved, and organic growth has held in the +4 to +6% band through the AI-disruption narrative cycle. That does not settle the debate, but it sets the watch-item: the day organic maintenance growth breaks below 3% across multiple aggregators, the bear case starts to validate.

6. The Metrics Professionals Watch

VMS aggregator quality is measured on a tight set of metrics that diverge from standard SaaS. Forget ARR growth as the headline — the right scoreboard is built around how much cash got deployed, at what return, with what retention.

A useful mental shortcut: a VMS aggregator's intrinsic compounding rate ≈ organic FCF growth + (FCF deployed / market cap) × incremental IRR. With ~5% organic FCF growth, a deployment rate of ~5–7% of market cap per year, and a 20–25% incremental IRR, the long-run compounding rate sits in the 15–18% range. That is the math behind the industry's premium multiples — and the math that breaks if either the hurdle rate falls or deployment runs dry.

7. Where Topicus.com Inc. Fits

Topicus is the European pure-play in the public VMS-aggregator stack. It is not a generalist software company; it is a Constellation operating-group that was spun out in February 2021 and now operates as a pan-European serial acquirer of niche VMS businesses in 40+ verticals across 26 countries. Within the four-tier industry stack in Section 1, Topicus sits at Tier 3 (aggregator) with deal-sourcing concentrated in the Benelux core and an expanding ring across DACH, Nordics, Iberia, Eastern Europe, and — newly in 2025 — Indonesia.

8. What to Watch First

A reader checking whether the industry backdrop is improving or deteriorating for Topicus should track these signals in order. Each is observable in primary disclosure within a quarter or two of the underlying shift.

Know the Business — Topicus.com Inc.

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Topicus is not a software company in any normal sense; it is a Constellation-style capital-allocation platform that happens to own ~100 small European VMS businesses. The economic engine is redeploying free cash flow into more sticky niche software at a high internal hurdle rate, not building bigger products. The market is paying premium VMS multiples for the deployment runway — what it most likely underestimates is the embedded option in the 23% stake in Poland-listed Asseco, and what it most likely overestimates is how durable the hurdle rate remains as private-VMS multiples re-rate higher.

1. How This Business Actually Works

The flywheel is simple and old: collect ~70% recurring software fees from niche European customers (notaries, dentists, schools, municipalities, auto dealers), convert that to FCF at a 25%+ margin, redeploy nearly every dollar into more niche VMS at a 20–30% IRR hurdle, hold forever. Capex is 0.7% of revenue. The real "capital expenditure" is M&A, which shows up in investing cash flow — not the P&L — and that single accounting fact is why IFRS earnings ($49m attributable to TOI in FY2025) wildly understate the economic value of the operating engine ($472m of free cash flow on $1.82bn revenue).

Bargaining power sits almost entirely with Topicus, not its customers. The end customer is a tiny share of a fragmented base — no one can demand a discount — and the cost of ripping out the software exceeds three to five years of fee savings. Suppliers are essentially staff (66% of opex) and a small slice of third-party software. Working capital is structurally negative because maintenance bills are paid annually in Q1 (look at the 2.7x Q1 cash-flow seasonality). The constraint on this business is not demand. It is supply of acquirable VMS at the hurdle rate — i.e. the willingness of private European software owners to sell at multiples Topicus is willing to pay.

The one accounting detail worth understanding: management reports "Free Cash Flow Available to Shareholders" (FCFA2S) — operating cash flow less lease interest, term-loan interest, lease payments, and capex, then less the share attributable to non-controlling interests. FY2025 FCFA2S was $257m. The full-consolidated FCF figure used in valuation work is $472m. The $215m gap is the share owned by the minority partners (Joday Group, Ijssel Group, and Constellation) inside Topicus Coop. This is not a quirk to ignore: ~29% of the economic interest in the operating businesses belongs to those minorities, not to public TOI shareholders.

2. The Playing Field

Topicus runs the same playbook as four other public serial acquirers, plus its parent Constellation. The peer table below sets out what a Topicus shareholder is actually buying versus the alternatives. Three lines deserve attention: the EV/Sales premium Topicus carries over CSU and LMN despite being smaller, the acquisition deployment that is materially larger than every peer except parent CSU and Roper, and the FCF margin that sits in the middle of the pack — not the top.

TOI financials converted to USD at 2025-12-31 FX (€1 = $1.175). Peers report in USD. Multiples and percentages are unitless.

The reading: Topicus is paid a higher revenue multiple than its parent CSU and sibling LMN despite a slightly thinner FCF margin. That premium is not for quality of operations — it is for the runway. Topicus has a younger, smaller European deal funnel and the largest absolute deployment ramp of any peer in 2025 (the $485m Asseco stake is unprecedented for the group). The fastest way to test whether the premium is justified is to watch whether organic maintenance growth holds in the 5–7% band while M&A spend stays above 4% of market cap per year.

The competitive reality at the deal level matters more than at the public-market level. Within the Canadian VMS family — CSU, TOI, LMN — there is no direct competition: Constellation explicitly carves out geographies and verticals so that the three entities feed each other deal flow rather than bid each other up. Tier-2 peers ROP and TYL operate at $100m+ deal sizes and rarely touch the sub-$25m European bolt-ons Topicus prefers; they overlap as benchmarks, not bidders. The real competitors are private: Visma (Norway, PE-backed, ~$2.9bn revenue), AFAS (Dutch ERP, family-owned), Vitec (Sweden, listed in Stockholm), Chapter Group (Germany), and the rising tide of generalist PE and family offices that have entered VMS deal funnels since 2020. The arrival of generalist PE has pushed European VMS multiples paid up by an estimated 1–2 turns of revenue versus the pre-2020 norm — the single largest competitive headwind to the model.

3. Is This Business Cyclical?

The customer's purchase decision is non-cyclical (a notary does not stop running her practice management system in a recession), but two parts of the model are sensitive — and they hit in opposite directions, which is the unusual feature of the business. Professional services is mildly cyclical (customers defer customisation projects when IT budgets tighten); M&A deal flow is counter-cyclical (private VMS owners sell at lower multiples when the equity market is soft, which is exactly when Topicus deploys the most capital).

The picture above is the entire shape of the cycle in this business. Demand stayed healthy through the European software derating (maintenance organic stayed in the +6–7% band throughout). Services softened as customers paused implementation projects (services organic drifted from +3% in 2022 to -2% in FY2025). Deal flow exploded in FY2025 because private valuations finally reset — the $817m deployed in a single year (incl. Asseco) was more than the prior three years combined. The right way to read recessions in VMS is: plus for the buyer (lower entry multiples on M&A), neutral for the consumer business (maintenance grinds along), minor minus for services. Topicus is one of very few businesses in the public market where a recession measurably helps the long-run compounding rate.

The one cyclical cost worth flagging is funding cost: TOI ended FY2025 with $813m of debt against $384m of cash (net debt $430m, ~1.0x EBITDA), up from net cash of $72m at YE2024. The $520m of new debt funded the Asseco stake. The model still works at 1.0x leverage, but a sustained rate environment that pushes the company toward 2.0x without a corresponding step-up in deployed-capital IRR would compress the math. That is the cyclicality investors should track — not revenue.

4. The Metrics That Actually Matter

Forget the P&L. Net income attributable to TOI fell from $108m to $49m in FY2025 — almost entirely because the company switched its 23% Asseco stake from FVOCI accounting to equity method at cost, triggering a $261m one-time non-cash reversal. The IFRS earnings number is meaningless here. The metrics that drive compounding are these four:

Scorecard (1–10): where Topicus leads (deployment, retention) and lags (FCF margin) the peer group.

The picture: Topicus is the deployment champion of the peer set and the retention champion alongside CSU and TYL. It is notthe margin champion — that is structural, not a problem. The narrative the heatmap defends is that TOI's premium multiple is earned through reinvestment optionality, not through operating leverage.

The "dual deployment / IRR" frame matters more than any single number. The intrinsic compounding rate of a VMS aggregator equals organic FCF growth (≈4–6%) plus the FCF redeployed per year (as % of market cap) times the incremental IRR. With FY2025 deployment at ~6–7% of market cap and a 20–25% incremental IRR, the implied math gives 5% + 6.5% × 22% ≈ 6.4% + 4–6% steady-state = ~10–13% intrinsic value-creation rate. That justifies a 17x EV/EBITDA today. It will not justify it if deployment falls below 4% of market cap, or if incremental IRR falls below 15%. Those are the two breakable assumptions.

5. What Is This Business Worth?

The right way to underwrite Topicus is EV/FCF for the operating engine plus an explicit add-on for the Asseco stake. The consolidated EV/Sales and EV/EBITDA multiples in Section 2 are useful as scoreboard comps, but they conflate two different things: a high-quality serial acquirer trading on its deployment runway, and a separately listed $700m+ minority stake in a Polish IT services group with a totally different return profile. Treating them as one business mispriced the equity in either direction.

A simple way to sanity-check the equity is to size the operating engine separately from Asseco. At ~$12.5bn market cap and $472m of FY25 consolidated FCF (or $257m FCFA2S), TOI trades at 26x consolidated FCF or ~48x FCFA2S. Stripping the Asseco stake at its $694m carrying value — which is conservative if Asseco trades at or above PLN 85 — gets you to roughly $11.8bn of equity value attributable to the VMS engine, or 25x consolidated FCF and ~46x FCFA2S. That is a structurally expensive number that only works if (a) the engine compounds FCF at low-to-mid teens for a decade, and (b) the company maintains its 20%+ IRR hurdle through cycles. The number does not work as a "cheap stock" play and never has. Investors who own TOI buy it for the compounding chain, not the multiple.

6. What I'd Tell a Young Analyst

One thing matters above everything else: track organic maintenance growth and capital deployed, every quarter. Maintenance is the leading indicator of customer health (the AI-disruption thesis would hit this line first); deployment is the leading indicator of forward returns. Both are disclosed quarterly in the MD&A. If maintenance organic prints under +3% for two consecutive quarters across Topicus, Constellation, and Lumine, the bear case is no longer speculative — it is in the data.

Three signals to watch alongside the metrics:

1. The Mark Leonard President's Letter (CSU annual report, usually published mid-February). Any softening of the 20–30% IRR target — even by tone — is a direct hit to the long-run compounding rate of TOI. The Leonard letter sets the hurdle rate for the entire family.
2. Asseco's WSE share price. Topicus now owns 23.14% of Asseco at a $694m carrying value, partially funded by debt. Asseco is a Polish IT services group with very different economics than VMS. If Asseco re-rates higher, TOI has hidden value the market hasn't priced. If Asseco underperforms, this becomes a value trap that drags consolidated returns.
3. The 46m diluted share count. Basic shares are 83.3m; fully diluted are 129.8m. That 1.56x dilution is already exchangeable into TOI common at 1-for-1, controlled by Joday Group (29%) and Ijssel Group (6%). If those exchanges happen, the float expands materially — and any per-share valuation work that uses basic shares is wrong by 56%. Always work in fully-diluted shares.

What the market is most likely getting wrong, in both directions. The bull error is treating TOI as a pure VMS roll-up and ignoring that the Asseco stake is now ~6% of enterprise value at a very different return profile. The bear error is reading the IFRS earnings collapse ($108m → $49m) as deterioration when it is a one-time accounting reversal tied to the Asseco re-classification. The clean cash picture (FCFA2S +23% YoY) tells you the engine is unambiguously stronger than a year ago.

The thesis-killer to keep at the top of mind: aggregator hurdle-rate compression. Generalist PE has flooded into European VMS deal funnels since 2020 and pushed entry multiples up by an estimated 1–2 turns of revenue. If that continues, the 20–30% IRR target eventually falls to 12–15% — and once the hurdle rate falls, the whole long-run compounding math compresses with it. This is the risk that does not show up in any quarterly disclosure until it has already happened. Watch the President's letter, the deal-count footnote, and any mid-sized acquisition where TOI publicly walks away. Those are the early reads.

Quality Score — Topicus.com Inc. (TOI)

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, multiples, share counts, percentages, and scores are unitless and unchanged.

The current quality profile is BA: the business clears the durability bar on recurring revenue (71% maintenance + recurring), exceptional cash conversion (FCF/OCF 0.97x), and a narrow but evidenced moat, while current management has reinvested cash at attractive returns and compounded per-share FCF at 19.7% CAGR since spin with no SBC and no equity dilution. The single biggest caveat is V — on the diluted FCFA2S denominator the stock prints near 34x rather than the headline 16x P/FCF, and the FY25 ROIC dip to 10.4% leaves Bear”s hurdle-compression read unresolved.

Scorecard

Where the evidence agrees and where it doesn”t

The strongest consensus is on the operating engine. Moat, financials, warren, forensic clean-tests, and people all point the same way: 71% recurring revenue, 90%+ retention, FCF/OCF 0.97x, capex under 1% of revenue, no SBC, no factoring, no aggressive operating-to-investing shifts, KPMG since spin with no qualification. That cluster — B, S, and the human/financial pieces of A — is the part of the file with the least disagreement.

The sharpest disagreement is V versus the rest. On the cash-relevant lenses the stock looks fair to attractive (EV/EBITDA 16.7x at the low end of post-spin range, P/FCF the cheapest in the peer set), but variant-claude”s rank-1 read is that the published denominator is wrong — FCF $472M leaks $216M to non-controlling interests inside Topicus Coop, so FCFA2S on the 129.8M fully-diluted count prints ~34x. That math has no margin of safety. The bear”s downside scenario ($42/share on FCFA2S compression to 18x) and the bull”s upside ($103/share on 20x P/FCF) define a wide range, and stan-claude”s verdict_label is Watchlist with side_that_wins = Bear. We mark V at 3 with medium confidence and read the disagreement as a definitional re-rating risk, not a fundamental break.

The weakest dimensions to watch are V and R. V moves up to 4 if Q2/Q3 FY26 ROIC mean-reverts to the 13-16% band and the post-Leonard CSU President”s Letter restates the 20-30% IRR hurdle without softening — both arrive inside the next two reporting cycles. R moves down to 3 if generalist PE entry compresses entry multiples another turn and forces a second non-VMS minority stake, which catalysts-claude flags as the cleanest test that the funnel can no longer absorb $470M+/yr at the historical IRR. A”s confidence is medium rather than high because the FY25 capital decisions (Asseco minority + $519M debt-funded ramp) have not yet earned a full year of operating income — the verdict on those specific calls is still pending. O is the dimension where additional evidence is most actionable: a coattail or sunset on the super-voting share, or a fully unaffiliated independent director, would move O from 4 to 5.

Competition — Topicus.com Inc.

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates (1 EUR ≈ 1.175 USD at 2025-12-31). Ratios, margins, multiples, percentages, and share counts are unitless and unchanged. Peer financials are USD-native and not re-converted.

Competitive Bottom Line

Topicus has a real but bifurcated competitive position. At the product layer the moat is intact: ~95% implied maintenance retention, +6% organic maintenance growth held through the entire 2022–2024 software derating, switching cost > 3–5 years of fee savings — none of the public peers, US or Canadian, prints a cleaner number. At the capital-deployment layer the advantage is narrowing: generalist private equity and family offices have entered the European VMS deal funnel and pushed entry multiples up by an estimated 1–2 turns of revenue versus the pre-2020 norm. The single competitor that matters most is not Constellation (parent, structural deal-flow ally) or any US public — it is Chapters Group plus generalist PE in the Benelux/DACH/Nordic deal corridor. That is the only force that can compress TOI's hurdle rate, and the hurdle rate is the entire long-run compounding math.

The Right Peer Set

The five comparators below are chosen because each illuminates a different aspect of the VMS-aggregator business model. Constellation is the parent and cycle-tested template. Lumine is the tightest comparison — same operating model, same parent, same age. Roper is the large-cap US benchmark for what TOI looks like at 5x its size. Tyler is the pure-play public-sector VMS comparator that maps onto TOI's ~30% public-sector exposure in NL/DE/BE. Descartes is the disciplined-M&A logistics-vertical comp that brackets the upper end of FCF margin in the peer set. The biggest gap in this set is the absence of a pure-play European listed VMS roll-up: Vitec Software (Stockholm, ~$220m revenue) is the closest analog but was excluded to stay within the five-peer target — flagged for future runs.

Snapshot 2026-05-14. Peer valuations from peer_valuations.json; all five peers report financials in USD natively. TOI EUR figures converted to USD at 1 EUR = 1.175 USD (2025-12-31 ECB rate). Multiples (EV/Sales, EV/EBITDA, margins, percentages) are unitless and unchanged.

Reading: TOI is paid a higher revenue multiple than its parent CSU and sibling LMN despite carrying a slightly thinner FCF margin. The premium is not for current operating quality — it is for the runway. The peer that sits visibly above the band is Descartes: a smaller, single-vertical, disciplined-M&A model with the highest FCF margin and highest revenue multiple in the set. That is the long-term operating template; TOI is closer to its parent CSU on the cost-and-margin axis, but with the deployment ramp of a younger, smaller, hungrier portfolio.

Where The Company Wins

Four advantages are concrete enough to point to in the data, not just in management commentary.

1. Organic maintenance growth is the cleanest in the peer set. Topicus printed +6% maintenance organic in FY2025 and held the +6–7% band through the entire 2022–2024 European software derating. Lumine — same playbook, same parent, same team philosophy — printed +2% organic maintenance in FY2025 (LMN MD&A: maintenance organic 2% for full-year 2025, with 0% in Q4). Constellation printed +9% maintenance organic in Q1 2026 but that figure includes USD/FX tailwind; ex-FX maintenance organic at CSU has run +5–6%, in line with TOI on a normalised basis. The implication: TOI's underlying customer health is at least as strong as its parent and visibly stronger than its sibling.

CSU figures FX-adjusted using management-disclosed organic in MD&A. LMN figures from LMN FY2025 MD&A page 4. ROP organic recurring revenue estimate from 10-K Application Software segment. TYL from 10-K (subscription growth normalised for ARR). DSGX organic estimate from MD&A and trailing services revenue.

2. Deal-flow ramp is materially larger than every peer except Roper. Topicus deployed $817m of capital in FY2025 — $331m of direct M&A plus a $485m minority stake in Asseco. As a share of market capitalisation, that is ~6.5% — the highest deployment ratio in the peer set, and the highest in TOI's own history. Lumine deployed only $14m of net M&A in FY2025 (against Topicus's $331m direct M&A) despite running the same playbook. The CSU FY2025 deployment of ~$1.3bn is larger in absolute terms but only ~3% of CSU's market cap — a function of CSU's scale. Deployment-as-percent-of-market-cap is the right metric for a serial acquirer, and TOI leads the peer set by that measure.

Roper's higher ratio reflects two single large transactions (CentralReach ~$1.85bn, Subsplash ~$0.8bn) at the upper end of US large-cap deal size. TOI's ratio is driven by bolt-on volume plus the one-time Asseco stake — a more flywheel-consistent pattern.

3. Decentralised perpetual-owner reputation is a sourcing edge that public-market peers cannot copy. TOI inherits CSU's "hold forever" promise — a screened reputation among European family-owned VMS sellers who care about employee continuity, brand survival, and not being flipped to PE in five years. Roper and Tyler both run centralised acquisition models with portfolio-company rebranding (Roper segments its acquisitions into "Application Software", "Network Software", "Technology Enabled Products"; Tyler integrates acquisitions into named product suites). They cannot credibly offer the perpetual-owner promise. PE-backed competitors can match the cheque size but not the hold horizon. The only public competitor with the same handshake is CSU itself, and CSU does not bid against TOI in Europe by design.

4. European deal-sourcing infrastructure at scale. Topicus.com employs ~10,000 people across 26 European countries serving 100,000+ customers in 40+ verticals (per Topicus.com About Us page). This is not a sales force — it is a deal-sourcing network. Local OpCo CEOs are the primary sourcing channel for adjacent acquisitions in their verticals, and the platform funnels those leads to a central M&A team that completed >40 transactions in FY2025. ROP, TYL, DSGX run thin US-headquartered M&A teams and would have to buy the European sourcing infrastructure TOI already owns to compete deal-for-deal in the sub-$24m European bolt-on funnel.

Where Competitors Are Better

Topicus is not the best business in this peer set on every axis. Four areas to be honest about.

1. Descartes prints structurally higher FCF margins — 36% vs TOI's 26%. DSGX runs a single-vertical, single-platform logistics network with a much higher recurring-revenue mix (~90%+ network/SaaS) and almost zero hardware/services pass-through. TOI's 26% FCF margin is dragged down by acquired companies still carrying services labour (24% of TOI revenue) and hardware (3% of revenue). The peer-set ceiling on FCF margin for an aggregator-of-aggregators model sits around 28–30%; DSGX's 36% is achievable only by staying narrow and refusing the diversification TOI has chosen. TOI's lower margin is structural, not a defect — but it is a real gap.

2. Roper deploys absolute capital at a scale TOI structurally cannot match. Roper completed $3bn+ of single-target acquisitions (CentralReach, Subsplash, Procare, Transact Campus) in FY2024–25. TOI's largest direct M&A in FY2025 was well under $120m for a single target. As private VMS multiples on $1m–$24m revenue businesses get re-rated up by PE bidding, Roper's ability to write $1–2bn cheques for sole-source large platforms (where competitive intensity is lower because few buyers can write the cheque) becomes a structural advantage. TOI's deal funnel is more crowded.

3. Tyler runs a faster SaaS transition with cleaner ARR disclosure. Tyler's annual recurring revenue grew 11% in FY2025 to $2.06bn, and 87% of total revenue is recurring (FY2025 10-K). Topicus's recurring share — maintenance & other recurring — is only 71% of FY2025 revenue, and the company does not disclose a clean ARR metric. Investors who want a quick read on customer-base growth find it easier in TYL's disclosures than in TOI's MD&A. Tyler's disclosure quality is a meaningful comparative advantage for institutional investor access; TOI relies on the more opaque FCFA2S metric.

4. Tyler explicitly names Constellation Software as a competitor in its 10-K. Public-sector VMS in the US is one of the few areas where the Canadian VMS family does compete head-to-head with a US incumbent. Tyler's FY2025 10-K lists Oracle, Infor, SAP, Workday, CentralSquare, Thomson Reuters, Motorola Solutions, Axon, and Constellation Software by name in the Competition section. That naming is mutual recognition that TYL has won and is winning US public-sector RFPs against CSU operating groups. To the extent TOI has analogous European public-sector exposure (Dutch / German / Belgian municipal contracts), the playbook risk runs in both directions — TYL has reach into Europe via NIC's payments platform and AWS partnership.

Threat Map

Six threats sorted by severity. The two High entries are the ones that could change the long-run compounding math; Medium entries shave margin or pace; Low entries are scoreboard noise.

Severity (1–10): where each threat hits.

Reading: generalist PE and Chapters Group concentrate risk in the same place — deal-flow share and hurdle-rate compression. AI risk is real but localised to the "tech displacement" axis and not yet visible in the maintenance organic growth data. ROP/TYL European push is the lowest-severity threat in the matrix.

Moat Watchpoints

The five signals below are the ones an investor should track to know whether TOI's competitive position is improving or weakening. Each is observable in primary disclosure within a quarter of the underlying shift.

Current Setup & Catalysts

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Stock prices converted from C$ at today's CAD/USD ≈ 0.731 (derived from EUR/USD 1.1702 and CAD/EUR ≈ 1.6). Ratios, margins, multiples, dates, and counts are unitless and unchanged.

1. Current Setup in One Page

Topicus is down ~54% from its July-2025 high and trades within ~10% of its 52-week low at the exact moment the market is being given the single most thesis-relevant disclosure of the cycle: today's joint hybrid AGM (15 May 2026, 8:00 a.m. ET) is the first time CSI's new President Mark Miller addresses shareholders publicly — and the agenda explicitly lists his presentation on Artificial Intelligence, followed by a joint Q&A with TOI, CSU and Lumine management at 8:45 a.m. ET. The recent setup is bearish on the tape and mixed on fundamentals: Q1 FY2026 beat consensus revenue by 2.8% with +23% YoY growth and 5% organic, but headline EPS optically fell 24% (entirely the comparator Asseco mark-to-market) while sell-side has walked targets down a third over four months (RBC US$139 → US$117 → US$110; TD Cowen most recently raised to US$106). The next three months are dense — AGM today, Q2 print on 31 July — but the decision-relevant cluster (ROIC reversion, post-Leonard hurdle language, maintenance organic across the family) does not fully resolve until Q3 FY2026 (4 Nov 2026) at the earliest. Stock at US$68.55 (+3.8% intraday on AGM-day flows); the tape's open question is whether today's Q&A puts a floor under the discount, or extends the distribution.

Recent setup rating: Mixed.

---

2. What Changed in the Last 3-6 Months

The narrative arc. Six months ago the question on this stock was how much further can the multiple expand? — TOI was a top-quartile-EBITDA, top-decile-deployment compounder at peak multiples. Three months ago, after Leonard's departure, the Asseco minority stake closing, and the active death cross, the question became is the deployment engine quietly breaking? The Q1 FY2026 print last week answered one half of that question — operations are not breaking (revenue +23%, organic +5%, maintenance still compounding) — but left the other half open: whether the FY25 ROIC dip is a clean denominator effect, whether the Asseco move was opportunistic or scope creep, and whether the post-Leonard hurdle culture survives. What investors used to worry about: AI disruption and stretched multiples. What they worry about now: hurdle-rate erosion and a tape that won't bottom. What is unresolved: ROIC reversion and the language Mark Miller uses today and in next February's first post-Leonard President's Letter.

---

3. What the Market Is Watching Now

The live debate compresses to a single sentence: Is the FY25 ROIC dip a clean denominator effect that will mean-revert in FY26, or the first observable signature of European VMS hurdle compression? Today's AGM Q&A and the 31 July Q2 print are the next two observables that meaningfully update either side.

---

4. Ranked Catalyst Timeline

---

5. Impact Matrix

The matrix is sparse on purpose. Only six items meaningfully change the debate. Today's AGM and the 31 July Q2 print are the only catalysts inside the next 90 days that resolve tension rather than add information; everything else either has a tail of 3-6+ months or operates as a slower watchpoint.

---

6. Next 90 Days

The 90-day calendar is concentrated, not thin: today's AGM is the single highest-impact catalyst this year, and the Q2 print on 31 July is the load-bearing fundamental read. The intervening window (mid-May through mid-July) is sentiment-driven — sell-side PT revisions, Asseco WSE drift, and tape behaviour around US$60 / US$77 — but no further hard-dated company disclosure lands until Q2 release.

---

7. What Would Change the View

Three signals would force the debate to update inside six months. First, Mark Miller's tone today — whether the 20-30% IRR language survives unqualified, whether minority public-equity stakes are framed as opportunistic vs systematic, and whether AI is conceded as a competitive headwind in TOI's verticals — is the cleanest single read on whether the bear's "post-Leonard hurdle compression" thesis or the bull's "structure carries the moat" thesis is closer to the truth. Second, the 31 July Q2 ROIC print is the only forward observable the file flagged as decisive in verdict-claude; ROIC reverting toward 12-13% with bolt-on M&A reaccelerating from $20.6m back toward the FY25 $82m/quarter pace flips the verdict from Watchlist to Lean Long, while ROIC stuck sub-11% with deployment dormant validates the bear's structural-compression call directly. Third, maintenance organic growth across TOI + CSU + LMN — the only signal moat-claude names as a direct moat-killer — gets two reads in the next six months (31 July and 4 Nov). A sub-3% print at any of the three for two consecutive quarters would migrate the moat conclusion from Narrow to "not proven" and would justify the bear's 34× → 18× FCFA2S compression target on its own, with no help from the hurdle-rate debate.

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Bull and Bear

Verdict: Watchlist — the operating cash engine is unambiguously strong, but the decisive evidence (FY26 ROIC reversion, post-Leonard CSU hurdle language, tape inflection) is not yet in the file, and a hostile distribution tape removes any reason to chase. Bull is right that FY2025 was a record cash year being mispriced against a one-time non-cash Asseco reversal; Bear is right that ROIC collapsed to 10.4%, the Asseco minority stake is the first deployment outside the stated VMS framework, and the 34× FCFA2S print on the correct denominator is not a margin of safety. The debate hinges on a single question that the data does not yet resolve: is the FY25 ROIC dip a clean denominator effect from late-year acquisitions, or the first observable signature of hurdle-rate compression in a re-priced European VMS funnel? FY26 H1 ROIC and organic-maintenance prints are the load-bearing observables — both arrive inside the next two reporting cycles, and neither is currently in hand. Until then, the bull thesis is intellectually correct on operations but premature on tape; the bear thesis is intellectually correct on structure but unproven on direction.

Bull Case

Bull's price target is $103/share on 20× P/FCF applied to FY27 base-case FCF of $588m (≈ $90/share) plus ~$13/share for the Asseco stake at carrying value, equivalent to 32× FCFA2S on FY27 FCFA2S of $398m. Timeline is 18 months, anchored on Q1 FY2026 MD&A through FY2026 annuals (Feb 2027) — the first non-Asseco-distorted print of consolidated net income. The disconfirming signal is maintenance organic growth printing sub-3% for two consecutive quarters across TOI + CSU + LMN — the only observable that breaks the switching-cost moat thesis directly.

Bear Case

Bear's downside target is $42/fully-diluted share (≈ $5.5B equity value) on P/FCFA2S compression from ~34× to 18× as the compounder narrative breaks — FY27 FCFA2S of ~$305m (modest growth with hurdle compression) × 18× ÷ 129.8m diluted shares. Timeline is 12–18 months, anchored on the first post-Leonard CSU President's Letter showing any softening of the 20–30% IRR language. The cover signal is FY26 ROIC ≥ 13% AND organic maintenance ≥ +6% AND CSU letter restating 20–30% without qualification — that combination means the FY25 dip was a clean denominator effect and the funnel is intact.

The Real Debate

Verdict

Watchlist. Bear carries slightly more weight today because the structural arguments — NCI leakage, fully-diluted denominator, 34× FCFA2S on the correct math, and a distribution tape that has not reversed since the October 2025 death cross — are observable now, while Bull's anchor (FY26 ROIC reversion to 14–16% as the FY25 deployment cohort annualises) is a forward-looking claim that the file cannot yet verify. The decisive tension is what ROIC 10.4% means: a clean denominator effect from late-year deployment versus the first observable signature of European VMS hurdle compression. Bull could still be right — record FY25 cash, +6% maintenance organic, no SBC, audit clean, and a CEO with ~$2.6B of effective stock are not the fingerprints of a deteriorating compounder, and one quarter of mean-reversion would re-rate the operating multiple cleanly. The verdict moves to Lean Long on the joint condition of (a) Q1 or Q2 FY26 ROIC printing in the 13–16% band, (b) maintenance organic holding ≥ +6%, and (c) the post-Leonard CSU letter restating the 20–30% IRR target without softening qualifiers. Absent any of those three, the right institutional behaviour is to keep the file open, watch the next print, and refuse to chase a stock that the tape is still distributing.

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates for the rate table (FY2025 end: 1 EUR = 1.175 USD). Ratios, margins, multiples, percentages, and share counts are unitless and unchanged.

Moat — What Protects Topicus, If Anything

1. Moat in One Page

Verdict: Narrow moat. Topicus has a wide product-layer moat — switching costs that exceed 3–5 years of fee savings, ~95% implied maintenance retention, +6% organic maintenance growth held cleanly through the entire 2022–2024 European software derating — and a narrowing capital-allocation moat at the holding-company layer, which is the one that actually drives the long-run compounding math. The product moat is real and evidenced across cycles; the deployment moat is hostage to private-equity entry into the European VMS deal funnel, the first AI risk-factor disclosure in the FY2025 MD&A, and a FY2025 capital-allocation deviation (the $485m Asseco minority stake) that sits outside the company's stated VMS strategy. A beginner investor should hold two ideas simultaneously: the underlying software businesses are genuinely defended; the premium multiple the market pays is for a reinvestment engine whose hurdle rate is opaque and is being tested in real time.

The conclusion is "narrow" rather than "wide" because the entire valuation case rests on the reinvestment engine, and that engine has three breakable assumptions: organic maintenance growth must stay above ~3% across the Canadian VMS family, capital deployed per year must stay above ~4% of market cap, and incremental IRR on deployed capital must stay above ~15%. All three are observable and all three have already started to drift in the wrong direction.

Moat rating: Narrow moat. Weakest link: hurdle-rate compression.

The two strongest pieces of evidence: (i) maintenance organic growth held in the +6–7% band through 2022–2024 even as the broader European software sector derated 30–50%; (ii) implied maintenance retention runs ~95%+ (inferred from +6% organic net of typical 3–4% price escalators implies churn under 2%). The biggest weakness: the 20–30% IRR hurdle inherited from Constellation is opaque, never quantified in TOI disclosure, and is the single number the entire valuation depends on — and PE entry has pushed European VMS entry multiples up by an estimated 1–2 turns of revenue since 2020 (René Sellmann deep dive, MOI Global Pillar fund profile).

2. Sources of Advantage

The table below catalogues every plausible source of advantage for Topicus and rates the proof quality. For a beginner, the key vocabulary: switching costs are the cost (in time, money, operational risk, retraining, data migration, regulatory compliance) the customer faces if they leave; scale economies are advantages that come from being big enough to spread fixed costs or sourcing infrastructure more efficiently than rivals; intangible assets include brands, data, regulatory licences, and reputational assets (here: the perpetual-owner promise to family-owned sellers); decentralisation is a management mechanism, not a moat — it matters only if it produces a measurable economic effect.

The honest read: of the eight candidate sources, two are High-proof (switching costs, customer fragmentation), three are Medium (deployment flywheel, sourcing infrastructure, perpetual-owner reputation), one is Low (regulatory tailwind), and two are not present (scale cost advantage, network effects). That is the shape of a narrow moat — strong on the product axis, contested on the deployment axis, absent on the dimensions a SaaS analyst's instincts would expect.

3. Evidence the Moat Works

Eight evidence items — both supportive and refuting. Cherry-picking is the easiest mistake in a moat write-up; the items below include the two strongest pieces of evidence against a wide-moat conclusion. The economic test of any moat is whether it shows up in retention, organic growth, pricing realised, margin durability, or capital deployed — narrative without measurement is not evidence.

The chart is the most important picture in this report. The blue line is the moat-relevant cut — the maintenance and recurring fees on which the entire switching-cost case rests — and it has not weakened. The red blended line is the headline number that bears point to; the gap between blue and red is professional services, which is cyclical (customers defer customisation projects in downturns) and not a moat axis. Conflating the two is the most common analytical error in this name.

4. Where the Moat Is Weak or Unproven

Four weaknesses. The first is the one that decides the investment.

1. The deployment moat depends on a 20–30% IRR hurdle the company never quantifies. Topicus's premium multiple (4.7x EV/Sales, 17x EV/EBITDA, ~26x FCF) is not paid for current operating quality — it is paid for the reinvestment runway, which is mathematically the spread between deployed-capital IRR and cost of equity. That IRR has never been disclosed by TOI. The 20–30% target is inherited from Mark Leonard's CSU framework and is implied, not stated. If PE entry compresses entry multiples by another turn of revenue, the realised IRR drops to 15% — and at 15%, the long-run compounding rate falls from 12–15% to 7–9%, which the multiple does not support. The single most important fact in this report: the moat case is hostage to a number that is not disclosed, on a deal funnel where the price has been moving in the wrong direction.

2. The FY25 capital-allocation deviation (Asseco) is unprecedented. The $485m minority stake in publicly listed Asseco Poland is the first capital deployment outside the original VMS-control framework. Equity-method accounting under-states fair value swings; the partial unwind from 25% to 23.14% in December 2025 suggests internal recalibration. Asseco is a Polish IT-services group, not a VMS aggregator — likely 8–12% steady-state return profile vs the 20–30% VMS hurdle. If "we will do another Asseco" becomes the pattern, the implicit hurdle rate has already softened; if the Asseco move is genuinely opportunistic, it does not. Today there is no way for an outside investor to know which.

3. The Asseco stake creates a "value trap" tail risk. Topicus now owns 23.14% of Asseco at $693m carrying value, partly funded by $519m of new debt. Asseco is publicly listed on the Warsaw Stock Exchange and depends on Polish governance and dividend policy. If WSE shares fall sustainably below TOI's PLN 85 cost basis, the consolidated returns drag; if Polish governance disappoints (atypical dividend behaviour, related-party transactions, regulatory action), the carrying value impairs. Either outcome is a negative without a corresponding upside that maps onto VMS economics.

4. The Mark Leonard step-down + AI risk factor disclosure happened in the same quarter. Leonard's departure as CSU President on September 25, 2025 — one day after a CSU call on AI — is a coincidence the market chose to treat as one. The Leonard President's Letter has set the hurdle-rate language for the entire Canadian VMS family for 20+ years; a softening of that language in the next letter would propagate directly to TOI's deployment discipline. Combined with the first AI risk-factor disclosure in TOI's FY2025 MD&A, the "the system carries the moat, not any single person" narrative is being tested for the first time.

5. Moat vs Competitors

The peer set is six aggregators chosen to cover every relevant operating model: parent (CSU), tightest sibling spin (LMN), large-cap centralised model (ROP), public-sector pure-play (TYL), disciplined-vertical model (DSGX), and the closest private comparator (Chapters Group AG, German VMS aggregator). The peer table makes one point clearly: TOI leads on retention and deployment-as-percent-of-market-cap and lags on FCF margin and disclosure quality.

Moat dimension scorecard (1–10) — TOI leads on deployment pace, sourcing, and retention; lags on FCF margin.

The heatmap defends the verdict: TOI's operating moat (organic growth, retention, sourcing, deployment pace) is at or near peer-best; TOI's margin moat is mid-pack and structural; the only place TOI lags meaningfully is FCF margin, where DSGX's narrower discipline produces a 10-percentage-point advantage. The peer comparison is medium-confidence because Chapters Group AG is private and its KPIs are sourced from third-party deep dives rather than primary disclosure — flagged as a data gap.

6. Durability Under Stress

A moat that only works in good weather is not a moat. The table below stress-tests the Topicus competitive position against six scenarios, including the two thesis-killers (PE-driven hurdle compression and AI commoditisation of long-tail VMS code).

The single most important durability stress is PE-driven hurdle-rate compression, because it operates silently — there is no quarter where the compression is announced. The compression shows up only in (a) the multiple paid on individual deals (rarely disclosed in granular form), (b) the realised IRR on the cohort, which is impossible for an outside investor to compute, and (c) downstream KPIs (ROIC, deployed capital as percent of market cap) that move only with a one-to-two-year lag. The right reflex for an investor is to treat any decline in CSU's President's Letter language about the 20–30% target as the leading indicator and to size positions accordingly.

7. Where Topicus.com Inc. Fits

The moat is not uniform across the Topicus portfolio. The company comprises ~100 operating businesses spread across 40+ verticals and 26 countries — and the moat varies materially by segment, geography, and product line.

The pattern is unsurprising: the moat is widest in public-sector and financial-services VMS (where regulation and integration depth are maximal), narrow in education and automotive (where SaaS-native competition and end-customer consolidation are pressures), and absent in the Asseco stake (which is a Polish IT-services minority investment, not VMS at all). Roughly 65–70% of TOI revenue sits in segments with a wide product moat; ~15–20% sits in narrower-moat segments; ~6% of enterprise value is in the explicitly non-moat Asseco bucket. The bull-case mistake is to assume the consolidated moat is the public-sector moat; the bear-case mistake is to assume the consolidated moat is the Asseco moat. The honest read is a barbell — most of the operating engine is genuinely defended, and a meaningful tail at the holding-co level is not.

8. What to Watch

Five signals. Each is observable in primary disclosure within a quarter of the underlying shift, and each maps to a specific decision an investor would make.

The first moat signal to watch is organic maintenance growth across TOI + CSU + LMN. It is the single observable that, if it breaks below +3% sustained across all three, validates the AI-disruption bear case and forces the moat conclusion down from narrow to moat not proven. Until then, the +6% maintenance organic at TOI is the strongest single piece of evidence in this report that the underlying competitive position is intact — and the entire valuation framework hangs on that line continuing to print.

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

The Forensic Verdict

Topicus screens as Watch (risk score 34/100). The operating engine — recurring-maintenance revenue, negative working capital, high deferred-revenue coverage, low capex — is faithfully represented in the cash-flow statement. The forensic risk is not in how revenue or operating income is reported. It is concentrated in three places: (1) the FY2025 Asseco Poland transaction, which dumped $260.5M of non-cash revaluation losses and $140.6M of derivative/dilution gains into a single year and forced a mid-year recast of Q1 2025 interim financials; (2) a structurally dense web of related-party arrangements with the controlling shareholder Constellation Software (CSI), the Joday Group, the Ijssel Group, Vela Software Group, and entities affiliated with the CEO and a key director; and (3) a non-controlling-interest structure where 35.8% of consolidated net income leaks to NCI before reaching subordinate voting shareholders. The single thing that would most change the grade is an audit-committee statement confirming KPMG had no scope or judgment disagreement on the Q1 2025 Asseco accounting treatment.

13-Shenanigan Scorecard

The pattern is clear: revenue, earnings, and cash flow from the operating business are clean. The forensic risk lives in non-operating line items — the Asseco transaction, the related-party constellation, and the structural cleavage between consolidated net income and net income attributable to subordinate voting shareholders.

Breeding Ground

The governance and incentive structure is a mixed bag — strong on equity-alignment hygiene, but heavy on control concentration and related-party density. Topicus is effectively controlled by Constellation Software Inc. (CSI) via a 10-vote multi-voting share class and the Joday Group's 29.4% non-controlling interest stake in Topicus Coop, which is exchangeable into subordinate voting shares. Three of eight directors (Mark Leonard, Robin van Poelje, Jamal Baksh) are non-independent; the CFO is not even paid by Topicus. KPMG LLP is up for re-appointment at the May 15, 2026 AGM and has audited the company since the 2020 spin-out — relatively short tenure for a Big Four engagement, with no qualification, emphasis paragraph, or material weakness on file.

The breeding-ground profile resembles CSI's: founder-anchored, equity-aligned, anti-promotional, audited by a Big Four firm, but with a tightly held control block and an audit committee that must scrutinize CSI-side transactions without a CFO who reports financially into Topicus. None of these are individually fatal — they are exactly the conditions that demand the forensic checks below.

Earnings Quality

Headline earnings are noisy. Reported FY2025 GAAP net income to Topicus shareholders was $49.1M, down 55% from FY2024's $108.1M — yet operating income rose 13% to $274.5M. The bridge from operating income to net income is dominated by a single non-operating item: a $260.5M revaluation loss recorded in Q3 2025 when Topicus elected to measure its Asseco Poland investment at cost under the equity method rather than at fair value through OCI. That charge offsets $140.6M of earlier-period derivative and dilution gains, plus $38.5M of FVTPL gains taken into earnings, plus $223.9M of fair-value movements that ran through OCI. The operating business kept compounding throughout — the noise is entirely below operating income.

Operating margins have stayed in a 12–18% band for seven straight years (FY2025: 15.0%) with maintenance-and-recurring revenue rising to 70.7% of total — that's the real earnings engine. The FY2021 net-income collapse to -$2.13B reflects spin-out share-based compensation accounting, not operating deterioration; this is well-documented in the inception prospectus and is an expected artifact of the Topicus Coop exchangeable-unit structure, not earnings management.

Receivables grew 22.0% in FY2025 against 19.9% revenue growth — a 2.1 percentage-point gap that is not a red flag at this scale, particularly when DSO actually improved from 51.7 to 49.1 days. Compare this to FY2019 where receivables outran revenue by 38 points: that was the early acquisition-driven scale-up, and unwound by FY2024. The trend is benign.

Deferred revenue grew 25% in FY2025 versus 20% revenue growth and added $42.2M from acquisitions — supporting the maintenance-prepayment narrative rather than overstated revenue recognition. Contracted-not-yet-recognized backlog of $1.53B at year-end (59% expected within 12 months) gives the FY26 revenue starting line strong visibility. Capitalized commission costs are a trivial $0.4M — Topicus is not propping margins via deferred sales-cost capitalization.

Cash Flow Quality

Operating cash flow conversion is real, not cosmetic. Adjusted for the $260.5M non-cash revaluation, the underlying CFO build comes from depreciation/amortization ($240M, all non-cash), prepaid maintenance contracts, and a $47.5M increase in deferred revenue. There is no factoring, no securitization, no supplier finance disclosed, and capitalized commissions are nil-material. The headline weakness is downstream: once acquisitions are subtracted, free cash flow available to deploy is roughly half of headline CFO, and once the $485M Asseco capital outlay is included, FY2025 generated negative invested-capital free cash flow.

CFO/NI is structurally inflated for two real (non-shenanigan) reasons: (1) intangibles amortization runs around $191M annually with no cash counterpart, and (2) the spin-out structure pumped non-cash share-based items through FY2021 net income. Ignoring those structural items, the operating business converts roughly 60–70% of EBITDA into operating cash — credible for VMS.

The CF build in FY2025 reveals the genuine story: $82M of GAAP net income + $240M of non-cash D&A + $261M of Asseco revaluation add-back + $33M working-capital benefit ≈ $484.9M of reported CFO. The working-capital lift is modest (7% of CFO) and is dominated by deferred-revenue inflows on prepaid maintenance — exactly what you'd expect from a 70%-recurring VMS business. DPO did stretch from 102 days to 113 days, contributing some payable-driven lift, but the dollar magnitude is small ($24M order of magnitude).

The compounder math: Topicus generates $485M of CFO but spends $332M on acquisitions, leaving $140M of true discretionary cash flow before the $485M Asseco outlay. Add the Asseco position and FY2025 was a -$345M cash-deficit year financed by a $520M increase in debt. Headline CFO/NI ratios will keep flattering this company until acquisitions slow. This is not a shenanigan — but it does mean that comparing TOI's $485M of FY25 CFO to peers' free cash flow without adjusting for the acquisition-spend run-rate misreads the durable capital return.

Metric Hygiene

Topicus's only repeated non-IFRS measure is Free Cash Flow Available to Shareholders ("FCFA2S"), defined in writing and reconciled line-by-line each quarter. The definition has not changed since the 2020 spin, and the reconciliation rigor exceeds most acquisitive software peers. The yellow flag is organic growth — the 4% figure cited as the FY2025 like-for-like growth rate uses estimated pre-acquisition revenues obtained from unaudited vendor financial information, with the company explicitly noting variances may be revised in subsequent quarters.

The two metrics worth a careful reader's attention are not on Topicus's metric page — they are buried in note disclosure. First, basic vs diluted share counts: at 83.3M basic shares the FY25 GAAP EPS is $0.59 but the 129.8M fully-diluted denominator (which includes exchangeable Coop units held by Joday, Ijssel, and CSI) is the economically correct base. Sell-side EPS using basic counts overstates the per-share economics by 56%. Second, NCI leakage: 35.8% of FY25 consolidated net income ($33.3M of $82.3M) accrues to non-controlling interests in Topicus Coop and individual operating-group subsidiaries (Sygnity 27.32% NCI, GeoSoftware and Geoactive each 40% NCI to Vela). Investors who model on consolidated net income systematically over-estimate the cash flow available to subordinate voting shareholders.

What to Underwrite Next

Five items to monitor in the FY2026 interim filings and the next annual report.

1. The Q1 2025 comparative recast. The MD&A states the Company "will recast the comparative interim period in its future filings in 2026" for the $36.9M net-income adjustment tied to Asseco accounting reclassification. Confirm the recast appears in Q1 2026 reporting without further revisions. If the recast widens beyond $36.9M, treat as a yellow flag escalation.

2. Asseco contribution under the equity method. With the 23.14% Asseco position now equity-method-accounted, expect 12 months of "share of net income (loss) of equity investees" to begin showing in Topicus's income statement. The transparency of which segment captures Asseco's contribution and whether it is broken out separately is the test. If Asseco's results are bundled into a generic "share in equity investees" line without disaggregation, that becomes a yellow flag.

3. Provisional purchase-price allocations. FY2025 acquisitions of $395.5M included provisional PPAs that "may differ from final PPAs and these differences may be material." Watch FY2026 disclosure for measurement-period adjustments to opening intangibles, deferred revenue, or contingent consideration. An adjustment exceeding 10% of provisional goodwill/intangibles would re-grade purchase accounting risk.

4. Related-party scope creep. Track three lines: (a) management fees to CSI ($3.5M FY25), (b) revenue from CSI affiliates ($12.2M FY25, up from $9.0M), (c) hosting/lease payments to CEO- and director-affiliated companies ($5.6M aggregate FY25). Any line exceeding 1% of total revenue or any new counterparty category warrants underwriting.

5. KPMG continuation. Re-appointment is a routine 2026 AGM item; non-continuation or new emphasis-of-matter language in the FY2026 audit report would materially re-grade the file.

The bottom line for position sizing: this is not a thesis-breaker. It is a forensic file that warrants a modest valuation discount versus pure-play SaaS peers — perhaps 1–2 turns of EV/EBITDA — and a discipline of valuing the business on net income attributable to subordinate voting shareholders and on fully diluted share counts. Investors who ignore the NCI leakage and the diluted share count will over-pay. Investors who understand them are looking at a faithfully-reported acquisitive compounder with one noisy non-operating year and a control structure they need to accept.

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. FY2024 figures use 2024-12-31 rate (€1 = $1.0389); FY2025 figures use 2025-12-31 rate (€1 = $1.175). Ratios, margins, multiples, share counts, and ownership percentages are unitless and unchanged.

The People Running This Company

Governance grade: B. Alignment is exceptional — the CEO holds ~$2.6B of effective stock, all bonus and director fees flow into open-market share purchases held in escrow ≥4 years, and there is no option dilution. The discount on grade comes entirely from structure: a single super-voting share gives Constellation Software 74.3% of votes with 31% of economics, and three of the four "independent" directors have current or prior CSI affiliations, so minority SVS holders have no governance lever.

1. The People Running This Company

Topicus is run by a deliberately small bench. Robin van Poelje runs the parent; three Operating Group CEOs run the businesses; the CFO function is contracted from the parent. There is no executive committee theatre and no founder mystique outside van Poelje.

van Poelje is the only person here whose personal wealth is genuinely tied to Topicus's share price; everyone else (including the CFO) is incentivised through a cash-bonus-converted-to-shares mechanism that builds a stake over time. The bench is thin by design — Constellation's "trust the operating groups" philosophy means corporate headcount stays small. The succession risk is real: a single C-suite exit at the top would force a transition without any obvious heir apparent on the public org chart.

2. What They Get Paid

FY2025 compensation is modest in absolute terms for a company with $2.0B+ revenue and a $5.9B+ market cap. The CEO earned $2.14M total — roughly the same as one operating-group CEO. The structural feature that matters is not the size of pay; it is that 75% of every executive's after-tax bonus is mandatorily used to buy SVS on the open market and lock it up for ≥4 years.

CEO pay rose 29% YoY in EUR terms (46% YoY in USD due to euro strengthening) and Operating-Group CEO pay rose 68% — both driven by higher ROIC × net-revenue-growth multipliers, not by salary increases (base salaries were essentially flat). The bonus formula nets a 5% risk-free hurdle off ROIC before any payout, which is the same hurdle Constellation has used for two decades. There is no SBC plan, no option grant, no RSU programme — incentives are entirely cash that becomes equity via open-market purchase.

Director fees follow CSI's template: C$60,000 base plus C$20,000 per committee, with the after-tax portion mandatorily invested in SVS held in escrow for four years. No equity grants, no special retainers, no consulting fees on the side — the proxy explicitly confirms zero professional services rendered to the company outside director duties.

3. Are They Aligned?

This is where Topicus is most distinctive. The cap table makes the alignment question more nuanced than headline ownership numbers suggest.

The single Super Voting Share owned by CSI is the entire governance story. CSI holds 31% of economic value but 74% of votes. van Poelje owns 29% of the company economically but has essentially no votes — his 37.5M Coop units have no voting rights until exchanged, and even after exchange would only dilute CSI's stake marginally. Outside SVS holders (33% economic) hold 26% of votes. In any contested vote, CSI alone decides.

Insider activity

The proxy states no material related-party transactions in FY2025. External insider-trade aggregators show small net selling — InsiderScreener.com records ~$89k net insider selling over the trailing 90 days (originally C$123k), dominated by routine executive disposals rather than directional bets. The structural buying pressure from mandatory bonus reinvestment in SVS is materially larger than any selling, so on a net basis insiders are accumulators, not distributors.

Dilution

Share count has been stable at ~83.34M SVS since the spin-off. Topicus does not issue stock options, does not grant RSUs, and does not run an ESPP. The "shares for bonus" programme purchases SVS on the open market — it does not issue new shares. Total fully-diluted share count (incl. exchangeable Coop units) has been ~129.8M for several years. Acquisitions are funded with internally generated cash and, since 2025, a $235M Schuldschein loan rather than equity issuance.

Capital allocation behaviour

Management speaks in Constellation's idiom on every call: hurdle-rate discipline, decentralised operations, no quarterly guidance, and no dividend (vs CSI which pays a small one). The Q1 2026 call explicitly states they will "invest all of our FCFA2S in acquisitions which meet our hurdle rate" with "uncommitted cash flow available to shareholders if we do not make any acquisitions". The 14.84% Asseco Poland investment completed October 2025 is the first large minority-stake deal — a stylistic departure that bears watching, but Asseco is a credibly compounder-grade target rather than a vanity acquisition.

Skin-in-the-game score

Score: 9/10. The one point withheld reflects (a) the dual-class structure that decouples voting from economics for the CEO himself — he is aligned but voiceless — and (b) the lack of any sunset or coattail trigger on the super-voting share.

4. Board Quality

The Board has five directors after Jane Holden did not stand for re-election in May 2025. Four are "independent" under NI 58-101; only van Poelje is a non-independent insider. The substantive question is whether the four nominally independent directors can actually challenge the controlling shareholder.

Board Quality Scorecard (0 = weak/conflicted, 3 = strong).

The Audit Committee (Macdonald, Parr, O'Neill) is fully credentialled — three financially literate members including a Big-Four-trained FCPA who chaired a tech-company audit committee. The CNHR Committee oversees compensation under the same nominal independence test. But the Board's structural test is whether it can disagree with CSI on a material decision, and the answer is no: CSI nominates three of the five directors directly, the Joday vehicle nominates one, IJssel nominates one, and the Chair of the parent (Billowits) sits on this audit committee.

This is governance built for a controlled-company model. It is internally coherent — the same alignment philosophy runs from CSI's board to Topicus's board to the bonus formula — but a minority shareholder who disagrees with a capital-allocation decision has no procedural way to register that disagreement beyond selling the stock.

5. The Verdict

Governance Grade: B

Strongest positives. This is one of the cleanest incentive structures in software. Cash bonus converts to open-market share purchases held in escrow for four years; no dilution; no option grants; a CEO with ~$2.6B of effective stock who has been with the company for 16 years; an audit committee that is genuinely financially literate; a CFO supplied by the parent at no cost to public shareholders; and a capital-allocation discipline (ROIC minus 5% risk-free hurdle, since-2014 model) that has compounded at the parent for two decades.

Real concerns. The dual-class structure with a single super-voting share is permanent — there is no sunset clause and no coattail provision. CSI's 74% voting power means the public-float SVS holders are passengers, not owners in any governance sense. Three of four "independent" directors have current or prior CSI affiliations, including the parent's current Chair sitting on Topicus's audit committee. The Board is small (five members) and there is no formal CEO/Chair separation. CFO services come from the parent — efficient but creates an information asymmetry where the parent always knows what Topicus's CFO knows.

What would change the grade. Upgrade to B+ if Topicus added a fully independent director with no CSI history (replacing one of the formally-independent CSI-affiliated ones), formally separated Chair and CEO, or introduced a coattail/sunset on the super-voting share. Downgrade to C if the parent extracts value via a non-arm's-length transaction (e.g. a forced acquisition of a CSI-portfolio company at non-market terms), or if van Poelje's incentive structure changes to reduce mandatory share investment, or if KPMG is replaced without a clean explanation. The most likely path is a slow drift in either direction depending on how the Asseco-style minority-stake deals perform.

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

The Story

Topicus has told one story for five years — acquire, manage and build vertical market software businesses in Europe — and the financials say it is the right story to tell. The plot point that did change came in 2025, when management quietly turned a $1.8B-revenue VMS roll-up into something with a $485M minority stake in a publicly listed Polish IT conglomerate (Asseco). Nothing about that pivot was telegraphed in prior MD&As. Yet there were no missed quarters, no walk-backs, and no narrative gymnastics to justify it: the disclosure was immediate, the accounting choices were spelled out, and the operating engine kept compounding underneath. Credibility is high; the open question is whether the story is still as simple as management implies.

1. The Narrative Arc

Topicus was spun out of Constellation Software on January 5, 2021. Founding CEO Daan Dijkhuizen stepped down on November 25, 2021, replaced by then-Chairman Robin van Poelje — the CEO since, and the architect of the strategic chapter the company is in today. The first four years (2021–2024) were a textbook decentralized tuck-in roll-up: small VMS acquisitions, recurring-revenue compounding, no formal guidance, no investor conference calls. 2025 was the inflection: a $485M deployment into Asseco Poland, the company's first inaugural unsecured topco debt ($234M Schuldschein), and a 27% expansion of the revolving credit facility.

The shape is consistent: revenue compounding ~21% CAGR since spin-off, FCFA2S compounding faster (~58% CAGR off a low base), and one year — 2025 — where reported net income to equity holders collapsed by ~$60M because of a one-time non-cash $260M accounting reclassification on Asseco. Strip out Asseco accounting, and the operating story is still a straight line up and to the right.

2. What Management Emphasized — and Then Stopped Emphasizing

Topicus's quarterly disclosure is unusually formulaic. The Overview paragraph has been word-for-word identical in every MD&A from Q1 FY2023 through Q1 FY2026 — same five sentences, same definitions of revenue lines, same acquisition framing. That linguistic stability is a feature, not a bug: it means deviations matter.

Topic Frequency in MD&A Disclosure (0 = absent, 5 = central).

Three patterns are worth naming:

Things that quietly disappeared. The Constellation bridge loan — front-and-centre in every 2021–2022 disclosure — was repaid in July 2023 and now appears only as a historical footnote. The 2022-era interest-rate-cap gains (worth $6.4M in FY2022) vanished from the narrative entirely by 2024 once derivatives ran off. Both are signs of a company that gradually severed dependencies on its parent and on interest-rate windfalls.

Things that appeared without warning. Asseco Poland is mentioned zero times in any disclosure through FY2024. By Q1 FY2025 it is the largest single capital deployment in company history, and by year-end FY2025 it accounts for more than 20% of total assets. The AI risk factor was added to the FY2025 annual MD&A — the first new substantive risk factor added since the December 2020 spin-out prospectus.

The phrase that never changes. "Acquire, manage and build vertical market software businesses" — six consecutive years, every quarter. That kind of linguistic discipline is rare and signals management treats the framing as identity, not marketing.

3. Risk Evolution

For four years, the Risks and Uncertainties section in every MD&A literally pointed readers back to the 2020 prospectus and added nothing. FY2025 broke that pattern.

Risk Profile, MD&A Lens (0 = silent, 5 = prominent).

What got louder:

• The Dutch tax authority's ongoing challenge of Topicus's employee bonus deduction (originally framed as a 2016 issue with $8.4M exposure in FY2023, escalated to "2016 and 2018 to date" with $9.4M exposure by FY2025). This is the only litigation-style disclosure that has grown in detail year over year.
• Contingent-consideration / earnouts — as M&A volume scaled from $145M (FY2023) to $395M (FY2025), the fair-value derivative liability tied to acquisitions grew to $78.7M of maximum exposure at year-end 2025.
• Public-equity volatility — entirely new from FY2025: a 23%-owned, PLN-denominated, publicly-traded Polish IT services company now drives a material portion of GAAP earnings via fair-value / equity-method swings.

What got quieter: the Constellation bridge-loan / temporary-financing language disappeared after 2023. Interest-rate-cap and finance-cost commentary moderated as European rates plateaued. None of the original 2020-prospectus risks were ever explicitly withdrawn — management simply stopped repeating them.

The new entry: AI was added as a formal risk factor for the first time in the FY2025 MD&A — both as a competitive threat (AI may "reduce barriers to entry" in VMS verticals) and a regulatory one. That single addition is more candid about AI than most VMS peers have been.

4. How They Handled Bad News

Topicus does not hold earnings calls. Every disclosure goes out through written MD&A. That removes the live-Q&A pressure but raises the bar on whether bad news is voluntarily surfaced. Three episodes test that bar.

The pattern is consistent with Constellation-family disclosure: operational softness gets a number, never a paragraph; accounting events get a paragraph, never spin. The Asseco $260M revaluation in Q3 2025 is the cleanest example — it took quarterly net income to $(142)M (vs +$43M in Q3 2024). Management did not bury it, did not adjust around it, and did not redefine FCFA2S to make it disappear. They walked the reader through the FVOCI vs equity-method accounting election step-by-step. The next quarter, FCFA2S resumed compounding at +40% YoY.

What is not addressed is the organic-growth deceleration. Organic growth has fallen from 8% (Q1 FY2023) to 4–5% (every quarter of FY2025 and Q1 FY2026). The quarterly tables show this in plain numerals, but no MD&A paragraph has ever discussed why, or whether management views the slowdown as cyclical or structural. That is the single biggest narrative gap.

5. Guidance Track Record

Topicus does not give financial guidance. There are no revenue, EBITDA, FCF, or M&A targets. What there are, are recurring commitments — phrased identically across years — that the company can be measured against.

Credibility: 8 / 10. The reasons for not awarding a higher score:

1. The Asseco pivot was not telegraphed. A $485M investment outside the stated "VMS roll-up" framing arrived without preamble. Whether you read this as opportunistic excellence or scope creep depends on whether the investment thesis (large Polish IT consolidation, public-equity arbitrage at PLN 85) plays out. The disclosure after the fact is exemplary; the framing before it is absent.
2. Organic growth deceleration is undiscussed. Falling from 8% to 4% organic over three years deserves at least a sentence of management context, which has never appeared.
3. Hurdle rate is opaque. Management's stated test for capital allocation is whether acquisitions "meet our hurdle rate." That hurdle has never been quantified, and the Asseco minority stake — a public-equity investment, not a control acquisition — was nonetheless described as fitting the same framework.

The case for the high score: every other commitment that was made has been delivered, including ones (Schuldschein, Asseco regulatory close) on tight, externally-visible timelines. Bad accounting news is voluntarily and clearly disclosed. No quarter has been restated except for the Asseco classification issue, which management surfaced themselves.

6. What the Story Is Now

The current story is best read as two stories layered on the same balance sheet:

1. A $1.8B-revenue, ~20% growth, 14% FCF-margin pan-European VMS compounder with 100,000+ customers across 26 countries, organic growth running 4–5%, and an M&A engine deploying ~$395M per year of cash into tuck-in software businesses. This is the original story, intact, and has not been walked back from.

2. A ~23%-owned, publicly listed Polish IT services consolidation play (Asseco Poland) representing ~21% of consolidated total assets, contributing the only volatile GAAP line in an otherwise predictable income statement, and partly funded by Topicus's first inaugural unsecured topco debt issuance.

"My commitment to the success of Topicus.com remains complete and unchanged." — Robin van Poelje, May 2024, on accepting the part-time Your.World CEO seat

The line is the only direct quotable communication from the CEO outside MD&A in the period reviewed. It matters because, in a company that otherwise communicates entirely through filings, this is the closest the reader gets to a personal commitment from management — and the only one offered when a question of focus could legitimately have been raised.

Financials — What the Numbers Say

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

1. Financials in One Page

Topicus is a European vertical-market-software (VMS) compounder running the Constellation Software playbook: dozens of small, mission-critical software businesses bolted together, run decentrally, and funded by their own recurring cash flows. Revenue has compounded from $408M in FY2018 to $1,824M in FY2025 — a 7-year CAGR near 24% — with EBITDA margins parked in a tight 27-33% band, FCF margins of 21-30%, and capex consistently under 1% of sales. The reason GAAP earnings look ugly (FY2025 net income $49M, FY2021 net income –$2,134M) is well-known accounting noise: non-cash IFRS finance charges tied to Topicus.B Exchangeable Shares and CSI Class A Preferred units that move with the share price, plus heavy amortization of acquired intangibles. Look at cash: operating cash flow of $485M and free cash flow of $472M in FY2025 — both records. The balance sheet flipped from net-debt-light ($151M, 0.3x EBITDA at YE 2024) to $545M (0.99x EBITDA) because management drew ~$520M in new debt to fund $332M of acquisitions and end the year with $384M of cash. The headline valuation looks expensive on P/E (158x on depressed earnings) but reasonable on the cash metrics: EV/EBITDA ~17x, P/FCF ~16-18x, EV/Sales ~4.7x — broadly in line with parent Constellation (CSU at EV/EBITDA 17.4x, EV/Sales 3.5x) and well below DSGX or TYL. The single financial metric that matters most right now is ROIC on incremental acquisition capital — the entire thesis rises or falls on whether Topicus can keep deploying $250-500M of cash a year into businesses that earn high teens returns.

---

2. Revenue, Margins, and Earnings Power

How Topicus makes money. Topicus owns ~120 European VMS businesses across healthcare, finance, education, government, and automotive. Each business sells mission-critical software to a niche industry where switching costs are high; revenue is a mix of recurring software licenses, maintenance/SaaS subscriptions, transactional fees (payments, financing), and a thin layer of professional services. Recurring + maintenance is the dominant slice — the rest is byproduct or runoff.

The growth pattern. Revenue compounded at 23.9% CAGR over seven years — a function of both organic growth (mid-single digits, per management commentary) and a steady drumbeat of bolt-on acquisitions ($53M in FY2018 rising to $332M in FY2025). The FY2021 step-up (+39%) and FY2025 step-up (+36%) both coincided with larger deal years. Operating income roughly tracked revenue but with two notable wobbles: FY2022 op income flatlined despite +16% revenue (heavy SG&A from acquisitions + integration friction) and FY2025 op income grew only +28% despite +36% revenue.

Margin interpretation. Margins are remarkably flat for a roll-up — that's the whole point of Constellation-style decentralization: don't centralize, don't squeeze for synergies, don't break the businesses. EBITDA margin has lived at 28-33% for eight years; FCF margin between 21-30%. The visible margin compression in FY2022 was acquisition-cost-driven (FY2021 deals weren't yet earning their full keep). FY2024 saw the strongest margin set (FCF margin 26.2%) and FY2025 held the line. Gross margin around 36% is structurally below pure-software peers like Descartes (77%) or Roper (69%) because Topicus's mix includes labour-intensive maintenance and professional services from acquired companies — that's a recurring point of confusion for first-time readers.

Recent trajectory: quarterly

Quarterly growth has re-accelerated through FY2025: revenue YoY grew 16% in 1Q25, 20% in 2Q25, 24% in 3Q25, 20% in 4Q25, and 23% in 1Q26. That re-acceleration matters because it is the first sustained pickup since the FY2022 deceleration and pushes the latest TTM growth rate to roughly 21%. Operating margin is seasonal (Q4 is always the strongest, ~17-20%; Q1-Q2 sits 13-15%) and the recent quarters are tracking the prior year's pattern, not breaking it.

---

3. Cash Flow and Earnings Quality

Free cash flow definition (read once). Free cash flow is the cash a business generates from operations after the spending required to keep its current asset base intact. For Topicus, the formula is straightforward: operating cash flow minus capital expenditure (capex). It excludes acquisition spending — those are growth investments, not maintenance.

The huge net-income-to-cash gap is structural, not a red flag. Notice the chart: net income tracks far below operating cash flow every year, and was deeply negative in FY2021 (–$2,517M consolidated, including the Topicus.B mark-to-market) and disproportionately low in FY2025 ($49M vs $472M FCF). The drivers of that gap, in order of size:

1. Acquired-intangible amortization (~$240M in FY2025, ~$176M in FY2024) — a non-cash IFRS charge for customer-relationship and software amortization on businesses Topicus has bought. Real economic charge if the asset wastes, but cash already left when the deal closed.
2. Topicus.B Exchangeable Shares mark-to-market — these CSU-held exchangeable shares are accounted for as a liability under IFRS, marked to fair value each quarter; when TOI's share price rises, IFRS creates a finance charge that hits pretax income but produces no cash outflow.
3. CSI Class A Preferred Units — similar dynamic; non-cash fair-value adjustments.
4. Working-capital benefit — Topicus runs a structurally negative working-capital cycle (deferred revenue from prepaid licences/subscriptions is large vs receivables), so revenue growth releases cash rather than absorbing it.

The gap between pretax income ($127M) and operating income ($274M) in FY2025 is almost entirely items 2–3. They are real to the GAAP statements but should not be deducted from earnings power.

Capex is trivial. Topicus spent $12.5M on capex in FY2025 against $1,824M of revenue — 0.7%. Capital intensity at the operating-company level is genuinely low; the real "growth capex" sits in the acquisitions line, which the cash-flow statement classifies under investing.

Cash-flow distortion	FY2025 ($M)	Cash or non-cash?	What it tells you
Net income	49.1	Cash-equivalent? No	Distorted by items below
Depreciation & amortization	240.0	Non-cash	Mostly acquired-intangible amortization
Working-capital benefit	~+100 (implied)	Cash	Deferred revenue grows with sales
Capex	-12.5	Cash	Tiny; under 1% of revenue
Acquisitions	-331.9	Cash	Investing line; the "real" growth capex
Dividends paid	0	n/a	None in FY2025 (FY2024 paid $132.6M special)
Debt drawn (net)	+497.9	Cash	Funded the acquisition step-up

---

4. Balance Sheet and Financial Resilience

What changed in FY2025. Net debt nearly tripled in a single year ($151M → $545M) and total debt more than doubled ($366M → $929M). The cash-flow statement shows why: management drew $520M of new debt, repaid only $22M, and spent $332M on acquisitions while ending with $384M of cash on hand. This is strategic rearmament for M&A, not distress. Leverage at 0.99x EBITDA is still firmly investment-grade by software-industry norms (and well below the 2-3x parent CSU has carried at points) but it is the highest the company has run since the spin-off, and it tilts the next-12-month story toward acquisition deployment, not balance-sheet repair.

Working capital — the structural cash machine. Current ratio is 0.62, which would normally trigger a red flag. For Topicus it is by design: deferred revenue from prepaid annual licences and subscriptions sits in current liabilities (alongside other accrued items), making the ratio look weak while the underlying cash dynamic is actively favourable. Receivables are $270M (DSO ~54 days), inventory is immaterial ($8M; this is a software business), and accounts payable of $429M largely reflects deferred revenue and prepaid customer balances. The negative working-capital posture means revenue growth funds itself rather than absorbing cash.

Intangibles dominate the asset side. $1,411M of goodwill and acquired-intangibles against $2,953M of total assets (48%), down from 72% in FY2018. Tangible book value per share remains negative (–$5.28 implied in FY2025) — entirely normal for a roll-up that has paid premiums for software businesses funded with debt and exchangeable shares.

---

5. Returns, Reinvestment, and Capital Allocation

Why returns matter most for this stock. Topicus is a compounder. The thesis is not "stable EPS at 15x" — it is "management redeploys ~75% of cash flow into new acquisitions at high-teens ROIC, year after year." If incremental ROIC stays in the mid-teens, intrinsic value compounds at growth + dividends + return-on-redeployed-cash; if it slips into single digits, the whole framework loses its rationale.

Interpretation. FY2018's 32% ROIC is a small-base anomaly; the durable corridor since the 2021 spin-off has been roughly 10-16% ROIC, with FY2024 hitting 15.8% and FY2025 dipping to 10.4%. The FY2025 dip is largely a denominator effect — invested capital ballooned with the debt-funded acquisitions late in the year, while the new businesses haven't yet contributed a full year of operating income. By the same logic, FY2025 ROE printed 7.6% on depressed (accounting-noise-impaired) net income; the operating-income-based return on tangible capital is closer to 18%. ROE through the cycle has averaged ~15-20% post-spin, consistent with mid-teens compounding.

What management does with cash.

• Acquisitions are the dominant use — $1.23B cumulative over FY2018-FY2025, peaking at $332M in FY2025 and $268M in FY2021. The acquisition pace is lumpy but persistent; it tracks the M&A pipeline more than the cash on hand.
• Special dividends are episodic, not recurring: $61.8M ($0.97/share) in 2021 right after the spin, then $132.6M ($1.60/share) in 2024. No regular dividend policy.
• Buybacks: none. No share repurchases are recorded in the cash-flow statement across the eight-year span. Share count is essentially static (basic shares 79-83M from FY2022 onward; fully diluted 129.8M including Topicus.B exchangeables).
• Capex is trivial (~0.6-0.9% of revenue).

Per-share progress is the right scorecard. FCF per share has gone from $1.55 in FY2020 to $3.64 in FY2025 — a 18.6% CAGR over five years, beating revenue growth on a per-share basis because dilution is being kept under control. Book value per share rose 66% in FY2025 ($4.25 → $7.07) on retained earnings and re-measurement of Topicus.B liability.

---

6. Segment and Unit Economics

The available data file data/financials/segment.json does not contain a structured segment-revenue breakdown for Topicus. From the company's published filings, the operating-group split mirrors CSU: management groups its acquisitions by vertical and geography but discloses limited segment-level financials beyond aggregate organic vs. acquired growth and a high-level revenue mix across recurring software, transaction processing, services and licenses.

What the filings do tell us:

• Revenue composition. Maintenance + recurring + SaaS revenue is the majority share (typically 70-80% of revenue for VMS roll-ups of this profile), professional services in the 10-15% range, hardware/license in single digits, and transactional payments/financing revenue an increasingly meaningful slice through subsidiaries like Total Specific Solutions and Topicus Finance.
• Geography. Operations are concentrated in the Netherlands (the historical core), Belgium, Germany, the UK, the Nordics, and selected DACH/Iberian footprints. North American exposure is limited and not the growth engine.
• Vertical concentration. Healthcare and finance are the two largest verticals by employees and revenue, with government, education, automotive, and legal each representing meaningful but smaller slices.

Without disclosed segment-level operating margins, we cannot isolate which segment carries the economics. Investor-facing reporting parallels CSU's habit of disclosing segment data only in broad strokes. The most informative organic-growth proxy is the gap between reported revenue growth and acquisition spending: FY2025's +19.9% growth on $332M of M&A implies low-to-mid single-digit organic growth, in line with the broader VMS roll-up cohort.

---

7. Valuation and Market Expectations

The setup. Topicus's TSXV ticker closed at C$91.81 on 2026-05-14 (data/prices/daily.json). With 129.8M fully diluted shares (basic + Topicus.B Exchangeable), market cap ≈ C$11.92B ≈ $8.7B (or ~€7.4B at spot FX). LTM revenue $1,824M; LTM EBITDA ~$515M; LTM FCF $472M; net debt $545M; enterprise value ≈ $9.2B.

Pick the right yardstick. For Topicus, P/E is misleading because earnings are depressed by non-cash IFRS charges; P/FCF and EV/EBITDA are the right primary lenses, with EV/Sales as a sanity check against the peer set.

Reading the history. TOI has traded in an EV/EBITDA band of 16-29x since the 2021 spin, with FY2025 sitting at the low end (16.7x). P/FCF has compressed steadily from ~21x to ~16x — implying the market has not paid more for the growth the company has actually delivered. EV/Sales sits at 4.7x, below the post-spin average around 5.2x. On every cash-relevant multiple the stock is at or below its post-spin historical range despite FY2025 being a record cash year and growth re-accelerating. That is the bull's strongest valuation argument.

Fair Value and Quality Score are not available in this run's rankings dataset (the diagnostic probe was missing).

A simple bear/base/bull frame on FCF

Applied to the current 129.8M share count: Bear = $47/share, Base = $82/share, Bull = $129/share — versus a current C$91.81 (~$67). The current price sits about a third of the way between bear and base — not a screamingly cheap setup, but not extended either, especially against the FY2024-2025 evidence of cash compounding.

---

8. Peer Financial Comparison

Topicus is one of the publicly traded VMS roll-ups. The natural peer set is:

• CSU — parent Constellation Software (TSX), same playbook at 8x scale
• LMN — Lumine Group, the other CSU spin-off, communications-focused
• ROP — Roper Technologies, US-listed serial acquirer at ~$8B revenue
• TYL — Tyler Technologies, US public-sector VMS specialist
• DSGX — Descartes Systems Group, logistics-focused VMS

Read the table. Topicus screens as the fastest-growing of the cohort (+20% vs 9-15% for peers), with EBITDA and FCF margins broadly in line with parent CSU. ROIC at 10.4% trails LMN (14.0%) and CSU (11.7%) — partly the FY2025 acquisition-denominator effect noted earlier; through FY2024 ROIC was 15.8%, comfortably above CSU. Balance sheet is more levered than DSGX/TYL/LMN (which carry net cash) but well under ROP's 2.6x and similar to CSU. On valuation, TOI trades roughly in line with CSU on EV/EBITDA, slightly cheaper on EV/Sales, and at the lowest P/FCF in the peer set — consistent with the historical premium TOI commands shrinking over the last 12 months.

The peer gap that matters: Topicus delivers the fastest growth at peer-average margins for a discount to parent CSU on P/FCF and EV/Sales. If the compounder model still works, that gap is harder to defend on operating metrics alone.

---

9. What to Watch in the Financials

Closing. The financials confirm Topicus is doing what a Constellation-style compounder should do: growing revenue mid-to-high teens organically-plus-acquired, generating record free cash flow, deploying that cash into more acquisitions, and keeping per-share metrics moving in the right direction. The financials contradict the headline P/E narrative — the 158x number is an artefact of IFRS noise, not of a business that has lost earnings power. The one place the financials are not yet emphatic is whether the FY2025 acquisition burst will earn its keep: a year of debt-funded M&A always lowers measured ROIC in the short term, and we need to see operating margin and FCF margin hold through FY2026 to confirm the new businesses are integrating without dilution.

The first financial metric to watch is ROIC trajectory through FY2026 — specifically whether ROIC recovers from the FY2025 dip (10.4%) back toward the FY2024 level (15.8%) as the acquired businesses contribute full-year operating income. If ROIC stays sub-12% for two consecutive years, the compounder story is in question; if it bounces, the FY2025 acquisition step-up will look like the right move.

What the Internet Knows About Topicus

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, and multiples are unitless and unchanged. TOI's share-price targets (in CAD) and Asseco's prices (in PLN) are kept in their native currencies because the relevant trading venues are the TSX Venture and the Warsaw Stock Exchange, respectively.

The Bottom Line from the Web

The filings document a serial acquirer; the web reveals a serial acquirer mid-pivot. Over 2025 Topicus moved roughly $430 million into a 24.83% strategic stake in Asseco Poland — its first sizeable public-equity minority investment, validated externally as the "PEMS" (Permanent Engaged Minority Shareholder) playbook copied from Constellation's SABRE investment — and that single deal explains the Q1 2025 earnings deferral, the FY2025 53% headline net-income drop, and most of the noise in Q1 2026's "21% net-income decline" that is in fact ~48% underlying growth. Layered on top: Mark Leonard stepped down as Constellation's President for health reasons (Mark Miller took over), removing the single most important capital allocator from the broader CSI complex, and that overhang — not deteriorating fundamentals — explains TOI's 50%+ drawdown from its CAD 199 peak.

What Matters Most

Recent News Timeline

Key Numbers From the Web

What the Specialists Asked

Governance and People Signals

Board changes: Jane Holden did not stand for re-election at the May 13, 2025 AGM; Lori O'Neill joined the board the same day. The remaining four directors — John Billowits (CSI overlap), Alex Macdonald, Donna Parr, Robin van Poelje (Chairman) — were re-elected without flagged dissent (source).

CEO external role: Robin van Poelje accepted a part-time CEO seat at Your.World in March 2024, with an explicit commitment-statement to TOI shareholders. No subsequent board pushback or analyst withhold-vote captured in the searches (source).

Mark Leonard step-down (CSI): Health-driven; Mark Miller (CSI COO) elevated to President. Leonard retains his board seat. The broader CSU/TOI/LMN basket sold off post-announcement, but no analyst captured in the searches argued the structure of the model breaks without Leonard.

Insider activity: TipRanks shows net sells totalling C$2.8M over the trailing three months. Individual identities and ticket details are paywalled. Small absolute amounts relative to TOI's roughly C$8B market cap, but the direction (sell, not buy) into a deep drawdown is the relevant signal — independent writers' "rare discount" narrative is not validated by insider behaviour.

Audit and accounting: KPMG remains the auditor. The Q1 2025 deferral was the only audit-adjacent disruption in the public record. The Asseco FVOCI → equity-method transition was the most significant accounting change in the company's history and was completed before FY2025 close. No qualified audit opinion or going-concern flag in the search results.

Industry Context

The 2025–2026 sell-off in TOI is not idiosyncratic. An equal-weight basket of VMS acquirers — Constellation Software, Topicus, Lumine Group, Roper Technologies, Vitec Software, and Chapter Group AG — underperformed the broader market by "a large magnitude" through the period (Compound With Rene, Part 1). The two narrative drivers cited consistently across independent writers:

1. AI disruption fear, mis-applied. Independent VMS analysts make a careful distinction: horizontal SaaS (Workday, Salesforce, ServiceNow) faces genuine generative-AI displacement risk because their use cases are general-purpose and data sets are large enough to fine-tune models on. Vertical Market Software targeting niches like Dutch local-government billing, Polish road authority traffic management, or German pharmacy chain logistics has TAMs too small and data sets too specialised to attract AI-native competitors. The market is pricing TOI as if it were horizontal SaaS; it isn't (Compound With Rene Part 1; Summit Stocks).

2. The Leonard departure overhang. Independent writers concede the risk but note the structure — decentralised operating-group autonomy, hurdle-rate discipline embedded in compensation, Topicus's own M&A team operating independently of CSI's — was designed to survive Leonard's exit. Mark Miller's elevation is presented as continuity rather than disruption.

Private competitive pressure: Visma (~$2.9bn revenue, Nordic/Benelux-focused, PE-backed) and Chapter Group AG (DACH) remain the most direct private competitors. Quantitative deal-flow comparisons (per-year acquisitions, average bolt-on multiples) are not publicly disclosed at the granularity required to test the hypothesis that PE inflow is compressing TOI's hurdle. The Asseco/PEMS pivot is implicitly a response: when private multiples are unattractive, TOI deploys into discounted public minority positions.

EU regulatory tailwind (pending): CAIDA, on the indicative Commission agenda for May 27, 2026, would tighten EU public-sector data-residency requirements — a structural tailwind for TOI's TSS Public, Blue, and Dutch/German/Belgian municipal-government lines if adopted. Currently a watch-list catalyst, not a confirmed driver.

Asseco public-equity stake as embedded option: Multiple independent analysts treat the 24.83% Asseco position as embedded option value: a current PLN 194 share price versus PLN 85 entry gives roughly +128% mark-to-market on a position now held at equity-method cost. Levered IRR estimates over a 10-year holding period cluster in the mid-teens percent range (The Compounding Tortoise). The position is the single most thesis-changing piece of information the web reveals that the filings' equity-method line item doesn't surface — it understates book value relative to fair value by a large margin.

Where We Disagree With the Market

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. CAD share prices and targets converted at CAD/USD ≈ 0.731 derived from EUR/USD 1.1702 and CAD/EUR ≈ 1.6. Ratios, margins, and multiples are unitless and unchanged.

The sharpest disagreement is on the denominator: every published target on this name anchors on a 16–18× P/FCF print on consolidated cash flow against basic shares, while the economically correct math — Free Cash Flow Available to Shareholders (FCFA2S) on a fully-diluted denominator — is ~48× and the cash that actually reaches public SVS holders is 45% smaller than the headline. The market is also mistreating the FY2025 ROIC collapse: sell-side has read 10.4% as the first observable signature of hurdle-rate compression, while the data fingerprint — $817m of capital deployed in the back half of the year with no time to earn — is overwhelmingly a denominator effect that should mean-revert in FY2026. And the Canadian VMS basket has been de-rated together (Leonard departure + AI fear + Asseco scope creep), pricing TOI as if its operational signals — +6% maintenance organic, peer-best deployment ratio, sibling LMN at +2% — were as soft as sibling LMN, when they are not. The variant view is neither a clean bull nor a clean bear: the operating engine is mispriced upward by the screen-quoted multiple and downward by the basket sell-off, and the resolution comes through ROIC reversion (or its absence), maintenance organic prints, and how sell-side denominators migrate over the next two reporting cycles.

Variant Perception Scorecard

The 62 variant strength reflects that the two sharpest disagreements (denominator and FY25 ROIC interpretation) push in opposite directions on the equity, which is itself an underwriting edge — the variant view is a paired correction, not a one-sided contrarian call. Consensus clarity is high because both sides of the published market view are observable: sell-side has cut three times in four months (RBC US$139 → US$117 → US$110; TD Cowen up to US$106; aggregate ~US$106 average), and a coordinated cluster of independent buy-side substacks (Summit Stocks, The Compounding Tortoise, Outsiders' Corner, Expanse Stocks) anchors the long-side narrative on the wrong denominator. Evidence strength is anchored by primary disclosure (FY2025 MD&A, NCI footnote, Q1 FY2026 results) rather than inference. Resolution in 6 months: Q2 FY2026 results on 31 July 2026 land the load-bearing ROIC observable; the Q3 FY2026 print (4 Nov 2026) laps the Asseco recast and is the first clean comparator.

Consensus Map

The published market view is internally inconsistent: the same sell-side that anchors a Buy on "lowest P/FCF since spin" is simultaneously cutting targets on the basket-driven ROIC narrative. That inconsistency is the structural opening — published consensus has not reconciled its own multiples with its own concerns. Our two highest-conviction disagreements sit on those two specific lines.

The Disagreement Ledger

Disagreement #1 — Wrong denominator. Consensus reads "16x P/FCF, lowest since spin" as a margin-of-safety entry; we read it as a screen artefact. The 1.56× gap between 83.3m basic shares and 129.8m fully-diluted (the Joday/Ijssel/CSI exchangeable Coop units, economically owners of 35.8% of consolidated NI) plus the 45% NCI leakage between $472m consolidated FCF and $257m FCFA2S together compress the true valuation by roughly a factor of three. The cleanest disconfirming signal is a sell-side note that publicly anchors on FCFA2S × diluted — once one major bank does this, peer notes follow, and the screen-quoted multiple loses its anchor without a fundamental catalyst. If a major sell-side house defends the basic-share, consolidated-FCF math explicitly in a follow-on note (as TOI's own controlling-shareholder structure has not changed since the spin), the variant view is weakened — we would have to argue why the market is only now getting the denominator wrong.

Disagreement #2 — Wrong reading of FY25 ROIC. Consensus reads 15.8% → 10.4% as evidence that European VMS multiples have re-rated and TOI is paying more for less. We read the timing of the dip ($817m deployed in H2 FY25 with no full-year earnings contribution) as a textbook denominator effect that will mechanically unwind. Consensus would say the company has never quantified its hurdle, so any ROIC math is inference — true, but the alternative explanation (clean denominator) is the simpler one and is internally consistent with management's Q1 FY26 behaviour (deleveraging breather, $20.6m bolt-ons only) which is what a disciplined hurdle-keeper does, not what a desperate deployer does. The cleanest signal is the 31 July Q2 FY26 ROIC print: above 12% and we are right; sub-11% with deployment still dormant and consensus is right. If the ROIC print comes in at 11–12% — exactly the grey zone — neither side wins and the debate extends to Q3.

Disagreement #3 — Basket discount, idiosyncratic operational quality. The Canadian VMS family has de-rated as a basket on the Leonard + AI + Asseco overhang. Inside the basket, sibling LMN prints maintenance organic +2% and deploys 0.4% of market cap. TOI prints +6% and deploys 6.5%. Consensus discounts both equally because the narrative drivers (Leonard, AI, basket positioning) are family-wide. Our variant view is that operating data should eventually dominate over basket positioning — the 4-percentage-point maintenance-organic gap and the 16× deployment-ratio gap are not narrative; they are quarterly disclosure. The cleanest signal is the relative move of TOI vs LMN inside the next two prints. If LMN improves and TOI rolls — basket wins, our variant view is wrong. If TOI extends operational lead while basket compresses uniformly, this disagreement compounds with #2.

Evidence That Changes the Odds

The audit logic for a PM: rows 1, 2, and 3 are the three load-bearing evidence items. Row 1 (NCI leakage and FCFA2S definition) is observable in the FY2025 MD&A; row 2 (ROIC mechanics) is observable in the balance sheet plus the acquisition timing; row 3 (organic maintenance) is observable in the quarterly revenue tables of TOI, CSU, and LMN. If any of those three reverse, the corresponding variant view weakens. None of the three are inference-only; all three are primary-disclosure.

How This Gets Resolved

What Would Make Us Wrong

The denominator argument is the easiest of the three to overstate. The 35.8% NCI leakage and 1.56× basic-vs-diluted gap have been public since the 2021 spin. If the market has not yet migrated to FCFA2S × diluted, the most charitable explanation is that the market has consciously decided the controlled-co structure does not warrant the discount — Joday and Ijssel are not selling exchangeable Coop units, no dilutive event has occurred for five years, and CSI's parent governance is famously aligned with public shareholders. If that interpretation is right, the "definitional re-rating" we describe never arrives, and the variant view #1 is wrong by being too procedurally cynical. The fragility we have to honor: a stable, structurally-aligned NCI may simply be priced as if it were not there. We would update our view if no major sell-side firm migrates to FCFA2S diluted within 12 months despite the FY25 forensic disclosure, or if a holder-rotation event compresses the spread between basic and diluted P/FCF math without operational catalysts.

The FY26 ROIC reversion argument is empirically falsifiable inside two quarters. If Q2 FY26 ROIC prints sub-12% and Q3 FY26 prints sub-12% again, with H1 FY26 bolt-on M&A below $117m, the "denominator-effect-mean-reverts" thesis has no remaining defence. We would have to concede that either (a) the FY25 acquisition cohort is structurally lower-margin than the historical book and the consolidated invested-capital base is permanently higher relative to operating income, or (b) the hurdle has compressed and management is correctly walking away from deals at the cost of deployment. Both readings — margin-mix and hurdle compression — are bear cases. The variant view fails if Q2 and Q3 FY26 both deliver this combination, and the right institutional response is to migrate the position size toward the bear's downside.

The basket-divergence argument depends on TOI continuing to print ≥5% maintenance organic while LMN stays at ≤2%. If LMN improves into the +4% band on its own (a Q4 FY25 0% print already inverts the trend), the operational gap that justifies idiosyncratic TOI alpha closes from 4 points to under 1. The basket then converges and our claim that TOI's quality justifies an undeserved discount loses force. The cleanest disconfirming event: a LMN MD&A in Q3 FY26 showing maintenance organic recovery to +4-5% combined with TOI rolling below +5%. That is observable, not inferred, and lands inside our 6-month window.

Beyond these three, the broader fragility is that consensus could be right on direction and we could be right on math. A sell-side analyst who is bullish on TOI for the wrong denominator reason and a bear who is bearish for the wrong ROIC reason can still both be cleaner directional bets than a variant view that requires the reader to hold two contradictory corrections simultaneously. Variant perception that is technically more accurate than consensus but does not translate into a cleaner directional position is research that produces more underwriting work, not more conviction.

The first thing to watch is the 31 July 2026 Q2 FY2026 ROIC print — a number above 12% with bolt-on M&A picking up from Q1's $20.6m re-validates disagreements #2 and #3 simultaneously and is the single observable that moves the most weight in our framework; a number stuck below 11% with deployment still dormant is the cleanest single piece of evidence the bear case will get inside this calendar year.

Liquidity & Technical

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, multiples, technical indicators (RSI, MACD, vol percentiles) and percentages are unitless and unchanged.

Topicus is illiquid by institutional standards — five-day capacity at a 20% ADV cap is only $17.1M, supporting a 5% portfolio weight for funds up to roughly $342M and nothing larger. The tape is firmly bearish: price sits 27% below the 200-day, an October-2025 death cross is intact, and the stock is parked one rally away from a new 52-week low while realized vol has just crossed into the stressed band.

1. Portfolio implementation verdict

2. Price snapshot

3. Five years of price action — and a regime change

Price is 27% below the 200-day SMA — a downtrend, not a pullback. The full-history view shows the stock round-tripping from a ~$77 IPO base, through a ~$223 cycle high in July 2025, back to $107 today. The most recent death cross fired 2025-10-28 at roughly $173; the 200-day SMA has been declining ever since ($186 → $147 in seven months) and price has remained below it for the entire stretch.

4. Relative strength — benchmark not covered

The standard broad-market reference for a TSX Venture-listed name is EWC, but the data feed returned an empty benchmark series for this run and no sector ETF or peer basket was constructed. Relative-strength signal therefore cannot be assessed from inside this report. Readers who need it should pair the price chart above against the iShares MSCI Canada ETF (EWC) externally; on absolute return alone, TOI's 1-year drawdown of −45% is more than double EWC's recent annualized range, so qualitative read is "lagging hard."

5. Momentum — RSI and MACD

Near-term momentum is neutral, not constructive. RSI is 45 and has not made an oversold print (under 30) since February 2026, when it touched 25 — so the snapback rally to $123 in early March used up the easy short-covering bid. MACD line and signal are both negative (−1.71 and −1.09) with the histogram drifting back down (−0.18 → −0.62 over the last four weekly observations), confirming the April bounce attempt has rolled. The 1-month return is −7.9% and the 3-month return is +6.2%, which together describe a stock chopping in a $103–$123 band while making lower highs.

6. Volume, volatility, and sponsorship

The signal: volume turned on as price fell. The 50-day average has roughly quintupled, from ~30k shares/day in mid-2025 to ~162k now — and the biggest single-day prints (Feb-Mar 2026, hitting 280k–500k shares) clustered on down days. This is the textbook signature of distribution by a previously concentrated holder base. The 2026-02-03 session printed 3.67× average volume with a −6.1% close — institutions reducing exposure into the break of $109.

Top three volume-spike days

The three largest volume multiples in the file all predate the current downtrend; absent named filings or news events tying these days to a catalyst, they read as concentrated-holder rebalancing rather than fundamental information events.

Realized vol at 48.6% is just above the historical p80 of 47.8% — a "stressed" regime in the company's own context, surpassed previously only during the 2022 software bear market and the late-2025 cycle-top reversal. Stressed vol on a stock that is also illiquid means execution risk is non-trivial: a single market order can move the print 3–5% on a normal day.

7. Institutional liquidity panel

A. Average daily volume and turnover

B. Fund-capacity table — what AUM can this stock support?

Reading the table from the fund side: a $340M fund can build a 5% weight in five days at a 20% ADV cap; a $1B fund cannot run more than a 1.5% weight without stretching to weeks. At a more conservative 10% ADV cap, the supported AUM halves — a $170M fund for a 5% line, a $850M fund for a 1% line. The largest issuer-level percentage that clears within five trading days is essentially zero: under any normal participation regime, even a 0.1% issuer position requires the full week to enter or exit.

C. Liquidation runway — days to exit common position sizes

A 1% issuer position ($140M) takes roughly two months to exit at a 20% participation cap, four months at 10%. A 2% position runs to a full quarter or more — meaning a holder of that size is structurally married to the stock unless markets cooperate or a block trade clears.

D. Intraday range proxy

The 60-day median daily range is 1.95% of price — close enough to 2% that a 50–100 bps execution cost on a market order should be the working assumption. Combined with the illiquid ADV, this is a stock where VWAP/POV algorithms with overnight extensions are the appropriate execution tool, not aggressive day-orders.

Bottom line on liquidity: The largest position that can be cleanly cleared in five days at 20% ADV is approximately $17.1M (worth 0.12% of market cap, or a 5% line in a $342M fund). At the more conservative 10% cap, the same five-day budget covers only $8.5M. Topicus is a small-fund / specialist-allocator stock.

8. Technical scorecard and stance

Stance — bearish on 3-to-6 month horizon, total score −4. The tape carries asymmetric setup risk to the downside: a declining 200-day SMA at $147 caps the upside without a multi-week base, while the 52-week low at $96.79 sits just 10% below current price with no proven support in between. Momentum is neutral rather than oversold (RSI 45 is not a contrarian buy print), and the volume signature of the last four months reads as ongoing distribution rather than capitulation. The two levels that change the view: a decisive weekly close above $123 (which would reclaim the 50- and 100-day SMAs together and clear the upper Bollinger at $122.53, signalling the downtrend has at minimum paused) flips the stance to neutral; a daily close below $96.79 (52-week low) breaks the next support and shifts the stance to "avoid until structure repairs." Liquidity is the constraint. Even if a fundamental investor concludes the stock has bottomed, building a meaningful position takes weeks at the current ADV — for any fund above $350M AUM the appropriate posture is watchlist with patient accumulation across multiple weeks, not chasing strength on a bounce.